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1.1. Apoptosis and necrosis in the brain  
!
Apoptosis and necrosis are two major paradigms of neuronal cell death and 
therefore leading causes for the devastating effects of progressive neuronal loss 
after acute brain damage and in neurodegenerative diseases [1-4].  
Necrosis is characterized by mitochondrial swelling, loss of ATP, massive calcium 
influx and dysregulation of the intracellular ion homeostasis. Later stages of 
necrosis are characterized by cell swelling, membrane lysis and induction of 
inflammatory processes by released intracellular components such as histamine or 
prostaglandins [5]. In neurodegenerative diseases neuronal cell death also features 
hallmarks of necrosis [6] for which reason a better understanding of necrosis 
pathways and their regulation is important to define new therapeutic targets.  
In contrast, apoptosis is characterized by nuclear condensation and DNA 
fragmentation, membrane blebbing and the subsequent formation of apoptotic 
bodies [7]. These apoptotic bodies have an intact plasma membrane and are 
phagocytosed for which reason they do not release intracellular components. 
Consequently, in contrast to necrosis, apoptosis does not induce inflammatory 
processes that could further increase the damage to the surrounding tissue [8]. For 
example, apoptosis is very important in proliferating tissue, for the replacement of 
senescent or excessive cells without causing necrosis, inflammation and scar 
formation [9].  
It is widely accepted that apoptosis is an active form of cell death requiring an 
energy dependent processing of apoptosis inducing factors, while necrosis 
traditionally has been regarded as a passive and uncontrolled form of cell death. 
However, recent findings suggest that this paradigm needs refinement, since a form 
of cell death has been reported showing features of both necrosis and apoptosis at 
the same time. The newly discovered form of cell death, named necroptosis shows 
signs of necrotic cell death, like plasma-membrane disintegration and mitochondrial 




Having been discovered only recently, the role of necroptosis in neurodegeneration 
is not yet established and is subjected to ongoing research. 
Apoptosis, however has been studied in great detail, revealing its physiological role 
in non-proliferating tissue like the brain, where apoptosis has been suggested to 
control the development of synapses by removing excessive and unneeded cells 
especially during brain development [11].  
In contrast to the physiological role of apoptosis, e.g. during brain development, 
pathological pathways of apoptosis have been associated with the progressive 
neuronal loss occurring in Alzheimer’s Disease and Parkinson’s Disease. Further, 
delayed neuronal death after acute brain damage caused by cerebral ischemia or 
traumatic brain injury also involved apoptotic-signaling pathways [4]. 
Overall, it is well established that apoptosis is of great importance in all organisms 
as it assures removal of damaged, senescent or mutagenic cells thereby preserving 
the maintenance and function of various tissues and organs. In contrast, 
dysregulation of apoptosis is known to cause diseases, including 
neurodegenerative disorders.  
Two different apoptosis-inducing pathways can be distinguished, the intrinsic and 
the extrinsic pathway (Figure 1). The extrinsic pathway is triggered by stimulation of 
death receptors, as for example, the Fas receptor that is activated by Fas-ligand 
(FasL). Such activation results in the sequential binding of Fas associated death 
domain (FADD) and procaspase-8, which thereafter becomes activated. 
Caspases are proteolytic enzymes that mediate apoptosis by cleaving important 
cellular proteins, e.g. actin or laminin, and by activating nucleases like CAD 
(caspase-activated deoxyribunuclease) that cleave the DNA in the nucleus and 
thereby induce cell death.  
Caspase-8 can directly activate the effector caspase-3, which has many substrates 
and is regarded as one of the key proteases in the execution of apoptosis. 
Caspase-3 causes release of CAD (caspase-activated deoxyribunuclease) from the 
inhibitory ligand ICAD and thereby CAD becomes activated. Together, caspase-3 
and CAD effect programmed DNA cleavage. 
Furthermore, the upstream caspase-8 can activate pro-apoptotic Bcl-2-proteins like 
Bid, which sets off the cascade of intrinsic apoptosis.  
In contrast to the extrinsic pathway, the intrinsic pathway of apoptosis is 




as well as activation of the pro-apoptotic protein Bid activate the intrinsic pathway 
and lead to mitochondrial permeabilization and the subsequent release of pro-
apoptotic proteins like apoptosis-inducing factor (AIF), cytochrome c, Omi/HtrA2 or 
Smac/DIABLO. Upon mitochondrial release, AIF rapidly translocates to the nucleus 
and induces DNA-damage and cell death in a caspase-independent manner [12]. In 
contrast, cytosolic cytochrome c forms a complex with Apaf-1 (apoptosis protease-
activating factor-1) and pro-caspase-9, the so-called apoptosome, which then 
catalyzes the activation of execution caspases like caspase-3 but also caspase-6 
and caspase-7 [13]. These caspases induce the breakdown of the cellular 
framework through the activation of CAD or degradation of substrates like actin. 
Further, alternative mechanisms of caspase activation during intrinsic pathways of 
apoptosis may be triggered by release of Smac/DIABLO or Omi/HtrA2 from 
mitochondria. In the cytosol Smac/DIABLO and Omi/HtrA2 block the anti-apoptotic 
protein XIAP (x-chromosomal linked inhibitor of apoptosis) and other inhibitors of 
apoptosis (IAPs) that usually inhibit caspase-activation. Consequently, upon 
mitochondrial release of Smac/DIABLO or Omi/HtrA2, caspases are released from 





Figure 1:!The intrinsic and the extrinsic pathways of apoptosis. (a) Extrinsic pathway: 
The death receptor Fas is activated by its ligand (FasL), inducing the binding of a Fas 
associated death domain (FADD). The death effector domain (DED) is bound to Pro-
caspase-8 and these proteins can bind to the Fas-associated complex and thereby causing 
the activation of capase-8. Caspase-8 can directly activate caspase-3 thereby inducing the 
release of CAD (caspase-activated desoxyribonuclease) from its inhibitory ligand ICAD 
inducing CAD-mediated DNA cleavage. Alternatively, caspase-8 can cleave the pro-
apoptotic protein Bid, which activates the intrinsic pathway of apoptosis that involves 
damage to mitochondria. (b) The cleaved Bid protein (tBid), increased calcium-levels or 
ROS induce mitochondrial membrane permeabilization causing the release of the 
mitochondrial proteins cytochrome c, Omi/HtrA2, Smac/DIABLO (Smac) or AIF. 
Cytochrome c forms a complex with Apaf-1 and pro-caspase-9, called the apoptosome. 
The apoptosome potentiates the activation of caspase-3. The x-chromosomal linked 
inhibitor of apoptosis (XIAP) is inhibited by the mitochondrial proteins Omi/HtrA2 and Smac, 
and consequently, caspase-3 and 9 are activated. When released from the mitochondria, 







































Many different triggers have been described for induction of neuronal apoptosis, like 
activation of ionotropic glutamate receptors followed by toxic calcium influx 
(excitotoxicity), loss of ATP, withdrawal of neurotropic factors and oxidative stress 
[14-17]. In Parkinson’s Disease, for instance, formation of ROS, mitochondrial 
dysfunction and activation of caspases are well-accepted mechanisms contributing 
to the degeneration of dopaminergic neurons [1, 18]. 
Glutamate-induced excitotoxicity is a major trigger of apoptotic pathways that 
mediate cell death in acute neuronal disorders like trauma or ischemic stroke. 
Ionotropic glutamate receptors like N-methyl-D-aspartate- (NMDA) receptors, 2-
amino-3-(3-hydroxy-5-methylisoxazol-4-yl)proprionate (AMPA) receptors or kainate 
receptors are activated by high levels of extracellular glutamate leading to 
increased intracellular calcium levels and the formation of ROS. The forced ROS 
production is due to mitochondrial membrane leakage and the activation of 
caspases, nitric oxide synthases or calpains [13].  
Excitotoxicity is a well-established cause of neuronal cell death inducing apoptosis 
or necrosis, depending on the strength of the insult, i.e. the concentration of 
glutamate over time, and particular conditions such as the availability of energy 
substrates and oxygen [19].  
The comparison of different neurodegenerative diseases reveals, that apoptotic 
mechanisms are highly conserved, even though the initiating triggers may differ 
among these diseases [6]. Until today, only a few drugs are available for the 
treatment of neurodegenerative diseases such as Parkinson’s Disease or 
Alzheimer’s Disease. However, the effect of these merely symptomatic therapies is 
limited, as they do not slow down the progression of neuronal demise. Therefore, it 
is important to understand the mechanisms of neuronal apoptosis in order to reveal 
novel targets for causal therapies.  
 
 
1.1.2.  Oxidative stress as mediator of neuronal apoptosis 
!
In the past reactive oxygen species (ROS) have frequently been linked to different 




also to neuronal death after stroke [20, 21]. ROS include molecules of highly 
diverse structures like oxygen free radicals (for example superoxide radicals or 
hydroxyl radicals) and peroxides like hydrogen peroxide or lipid hydroperoxides. 
Under physiological conditions ROS at low levels are involved in signaling 
processes and function as mediators in different processes like cellular growth and 
adaptation responses [22].  
In contrast, elevated concentrations of ROS can contribute to membrane damage 
and can alter DNA and unsaturated lipids as well as membrane proteins. ROS-
induced changes in the cellular membranes cause decreased activity of membrane-
bound ion channels, receptors and enzymes and thus influence membrane fluidity 
[23]. 
As described before ROS are important triggers of the intrinsic apoptotic pathway 
indicating the importance of ROS formation in neuronal damage. The excessive 
formation of ROS in neurons can be caused by different activators such as 
glutamate overload, !-amyloid-plaques [3, 14][24], oxygen-glucose deprivation and 
massive NO formation, among others [20, 25]. High levels of glutamate have been 
linked especially to excitotoxicity-induced ROS formation but it has been suggested 
that glutamate can also mediate oxidative stress independently of ionotropic 
glutamate receptors [26]. The mechanisms of glutamate-induced oxidative stress 
are not fully understood and, therefore, it is necessary to delineate neuronal 
glutamate toxicity in further detail. 
In order to investigate the mechanisms of oxidative stress in neurons HT-22 cells 
were used as a model system. These cells are immortalized mouse hippocampal 
neurons that are sensitive to glutamate. Since HT-22 cells do not express ionotropic 
glutamate receptors, glutamate-induced cell death is not mediated by excitotoxicity, 
but by glutathione depletion. High extracellular glutamate concentrations block the 
glutamate-cystine-exchanger Xc-, which usually mediates the transport of cystine 
into the cells. Consequently, glutamate reduces intracellular cystine-levels thereby 
blocking glutathione (GSH) synthesis [27-29]. Glutathione serves as a radical 
scavenger that sequesters free radicals and oxidizing species. Thus, with declining 
levels of glutathione the formation of ROS within the HT-22 cells increases and 
concomitantly ROS-mediated damage of intracellular structures (i.e. lipid 
membranes, proteins and DNA) is induced. Furthermore, it has been shown that 




death in HT-22 cells as it increases with some delay in response to the glutamate 
challenge [30].  
The increase in ROS and cytosolic calcium as well as the mitochondrial dysfunction 
are established key mediators of apoptosis, all of them detectable in cell death of 
HT-22 cells, rendering the model of glutamate toxicity in this cell line a valuable and 
applicable model for apoptosis induced by detrimental oxidative stress in neuronal 
cells. Thus, the underlying mechanisms of cell death in HT-22 cells challenged with 
millimolar concentrations of glutamate were termed oxytosis. However, the 
mechanisms of increased ROS formation and downstream oxytosis death pathways 
induced in the neuronal HT-22 cells required further investigation. 
In addition, primary neuronal cultures were used to explore oxidative stress in 
neurons in further detail. These cells express ionotropic glutamate receptors and 
therefore glutamate toxicity is mediated by excitotoxic activation of NMDA 
receptors, characterized by increased intracellular calcium levels in addition to 
glutamate-induced GSH-depletion and formation of ROS. 
 
 
1.2. The Bcl-2-proteins and mitochondria in neuronal cell death 
!
The Bcl-2 proteins are a family of pro- and anti-apoptotic B-cell lymphoma-2 (Bcl-2) 
proteins. These proteins are key mediators of mitochondrial damage and cell death 
[31]. All members of the Bcl-2 family share a close homology in characteristic 
regions named the BH (Bcl-2 homology) domains. To date, 4 BH domains have 
been identified (BH -1-4) [32]. It is important to note that some of the Bcl-2 proteins 
mediate apoptosis (e.g. Bax, Bak, Bad, Bim, Bid) and others prevent apoptotic 
mechanisms by interaction with the pro-apoptotic representatives (e.g. Bcl-2, Bcl-xl, 
Bcl-w). Bcl-2 and Bcl-xl, for instance, can prevent the pro-apoptotic function of Bax 
by the formation of heterodimer complexes with the pro-apoptotic protein [33].  
Bad, Bid, Bik/NBK, Bim/Bod, Bmf, Hrk/DP5, Noxa and Puma/BBC3 share only the 
BH-3 region with the other members of the protein family and therefore are named 
BH-3-only proteins. These proteins are exclusively pro-apoptotic and once activated 




mediate mitochondrial demise and cell death, proposing signaling network 
interactions between the pro-apoptotic Bcl-2 proteins. 
For example, the pro-apoptotic BH-3-only protein Bid and its truncated form tBid are 
involved in different pro-apoptotic pathways. The activation of tBid can induce the 
release of Bax from the Bcl-xl/Bax heterodimers. Furthermore, in the presence of 
activated Bid, Bax and Bak form a pore in the mitochondrial membrane and thereby 
allow the release of pro-apoptotic factors like AIF or cytochrome c [31, 34]  
As described before cleavage of the Bid protein is necessary for the activation of 
the intrinsic apoptotic pathway pointing out again the central role of the Bid protein 
[35, 36]. Pharmacological Bid inhibitors and genetic Bid deletion provided protective 
effects in different models of neuronal cell death. For example, Bid knockout mice 
showed less neuronal damage after trauma compared to wild type mice [37] and 
Bid-deficient neurons were protected against oxygen glucose deprivation (OGD) 
and cerebral ischemia [38, 39]. Further, Bid activation has been supposed to be 
involved in glutamate-induced oxidative stress [26] and after cerebral ischemia and 
death receptor signaling [38, 40].  
 
Several studies have suggested that the inactive full-length Bid is located in the 
cytosol and that cleavage of Bid is necessary for its activation and its pro-apoptotic 
function [41]. Caspase-8 is the most prominent activator of Bid mediating Bid 
cleavage e.g. after stimulation of TNF- or Fas- receptors. Caspase-8 activity was 
also found enhanced after OGD and also after cerebral ischemia in rodents [42, 43]. 
In addition, Bid can be cleaved by caspase-1 and also by caspase-2. This has been 
shown in models of ischemia and hypoxia for caspase-1 [49].  
In addition to caspases also calpains and lysosomal hydrolases are able to cleave 
the Bid protein. Calpains are calcium-activated proteolytic enzymes that metabolize 
protein kinases and phosphatases as well as cytoskeletal proteins and transport 
proteins among others [44, 45].  
Taken together, high levels of intracellular calcium resulting from glutamate-induced 
excitotoxicity can activate calpains and thereby mediate apoptosis. Once activated, 
calpains may cause mitochondrial damage via Bid cleavage and Bid transactivation 
to mitochondria and the subsequent release of pro-apoptotic proteins like AIF or 




ischemia or traumatic brain injury calpain inhibitors significantly reduced neuronal 
cell death indicating that calpain activation mediates acute brain injury [47, 48]. 
Interestingly, it is known that also full-length Bid can translocate to the mitochondria 
and induce loss of mitochondrial membrane potential and DNA-damage in 
glutamate-induced neurotoxicity [50]. In a model of epithelial cells, for example, full-
length Bid mediated apoptosis without being cleaved in advance [51]. In the model 
of HT-22 cells Bid cleavage was hardly detectable after glutamate treatment 
indicating that full-length Bid translocates to the mitochondria whereas only a small 
amount of Bid may be cleaved in HT-22 cells [52]. 
Overall, not only tBid but also full length Bid seem to be key mediators of apoptotic 
neuronal cell death. Therefore, the investigation of exact mechanisms induced by 
Bid and tBid is very important for further analysis of neurodegenerative processes.  
 
It became obvious that Bcl-2 proteins are linked to intrinsic pathways of 
programmed cell death mediating their pro-apoptotic function through mitochondrial 
damage.  
Mitochondria are essential organelles since they produce the main part of energy in 
the cells through ATP synthesis. On the other hand, mitochondria exhibit a crucial 
role in apoptotic mechanisms because they generate large amounts of ROS [53] 
and contain proteins like cytochrome c, AIF or Smac/DIABLO, which induce 
neuronal cell death once they are released from the mitochondria [53, 54].  
Thus, mitochondria are the central cellular organelles mediating the intrinsic 
apoptosis pathway that can be activated by different stimuli like for example 
increased calcium levels, pro-apoptotic Bcl-2 family members or reactive oxygen 
species [55].  
Mitochondria produce ATP by electron transfer from one complex of the respiratory 
enzymes to the next and finally to oxygen. At the same time protons are transported 
across the mitochondrial inner membrane creating a proton gradient, whose 
potential is the driving force of ATP synthesis, and an increase of the mitochondrial 
membrane potential. Since molecular oxygen and electrons are continuously 
processed in mitochondria, the potential role of mitochondria as a source and a 




Mitochondrial demise can be caused by several triggers including the disturbance of 
detoxifying mechanisms like GSH, glutathione peroxidase, superoxide dismutase 
(SOD) or catalase and also by high intracellular calcium levels (10-100 !M) [56].  
Increases in intracellular calcium occur after activation of glutamate receptors and 
by its release from intracellular stores like the endoplasmatic reticulum (ER).  
The pro-apoptotic members of the Bcl-2 protein family represent another potential 
trigger of mitochondrial membrane permeabilization [57]. As mentioned before the 
pro-apoptotic Bcl-2 family members Bax and Bak, for instance, may form a pore 
and thereby induce mitochondrial permeabilization and the release of pro-apoptotic 
proteins like AIF or cytochrome c [31, 58]. In addition, the pro-apoptotic Bcl-2 family 
protein Bid induces the intrinsic apoptotic pathway that involves mitochondrial 
membrane permeabilization thereby releasing pro-apoptotic factors from 
mitochondria that amplify apoptosis by caspase-dependent and caspase-
independent mechanisms. 
Mitochondria are dynamic organelles that continuously undergo fission 
(fragmentation) and fusion processes that are important for mitochondrial 
biogenesis, repair and for redistribution of mitochondria to parts where high 
amounts of energy are needed [59-61]. A disturbed balance of fission and fusion 
has recently been characterized as an important contributor to mitochondrial 
dysfunction and cellular death [61-63].  
Neurons require high levels of energy for which reason they are densely packed 
with ATP-synthesizing mitochondria. Consequently, disturbed mitochondrial 
function significantly affects neuronal function and survival. Under physiological 
conditions several proteins regulate mitochondrial fusion and fission processes, like 
Drp-1, Fis-1, Opa1 or mitofusins. Opa1 and mitofusin-1 and -2 (Mfn-1/-2) act as 
fusion proteins whereas Drp1 and Fis1 mediate mitochondrial fission [64]. 
Dysfunctions in the fission-fusion machinery have been linked to several 
neurodegenerative diseases, like Alzheimer’s Disease or Parkinson’s Disease [63, 
65, 66]. Consequently, fusion and fission proteins like Drp-1 are interesting targets 
for the therapy of neurodegenerative diseases and are currently explored in several 
scientific studies. 
Overall, it has been well established that activated Bcl-2 proteins and subsequent 
mitochondrial damage are important mediators of neuronal cell death but still the 




investigated the activation of pro-apoptotic Bcl-2 proteins and focused on upstream 
mechanisms of mitochondrial demise as well as on mitochondrial death pathways in 
neuronal cells in order to identify new therapeutic targets to prevent neuronal 
degeneration and death. 
 
 
1.3. Lipoxygenases in the brain 
 
Free membrane phospholipids like arachidonic acid (AA) and docosahexaenoic 
acid (DHA) can be oxidized in an enzymatic or non-enzymatic way to various 
oxygenated products, which mediate important functions in neuronal cells. The 
collective name for these metabolites is eicosanoids.  
Arachidonic acid is released from phosphatidylcholine by the cytosolic 
phospholipase A2 (cPLA2) and DHA is released mainly by the plasmalogen-
selective phospholipase A2 (PlsEtn- PLA2) [22, 67]. Enzymes like cyclooxygenases 
(COX), lipoxygenases (LOX) or epoxygenases (EPOX) metabolize AA and induce 
the formation of prostaglandins, thromboxanes, leukotrienes or epoxyeicosatrienoic 
acid, respectively. Eicosanoids are important effectors of signal transduction, gene 
transcription and inflammatory processes [22]. Neurons as well as astrocytes, 
cerebral vascular endothelial cells, and cerebrospinal fluid contain plenty of 
eicosanoids [22].  
Under physiological conditions leukotrienes and prostaglandins can, for instance, 
modulate glutamate receptors, thereby mediating the communication between 
prostaglandin-, leukotriene-, thromboxane- and glutamate receptors. Under 
pathological situations this crosstalk is disturbed and mediates neuronal damage 
that depends on the level of COX and LOX [22, 68].  
Prostaglandins and related eicosanoids are neuroprotective at nanomolar 
concentrations, which has been shown for example for PGE2 in hippocampal 
neurons in models of excitotoxicity and oxygen glucose deprivation [69]. However, 
micromolar and millimolar concentrations of PGE2, as occurring under pathological 





COX and LOX metabolize DHA to resolvins, docosatrienes and neuroprotectins 
[22]. Docosanoids is the collective name of these metabolites that antagonize the 
effect of eicosanoids and can also regulate the expression of cytokines by 
modulating the function of leukocytes [71, 72]. Different isoforms of COX, LOX and 
PLA2 are expressed in neuronal and in non-neuronal tissues [22] where they are 
involved in inflammatory processes, aging, apoptosis and synaptic activity in the 
brain [22]. 
In addition, it is known that disruption of the arachidonic acid (AA) cascade leads to 
increased production of ROS and hence oxidative damage of membrane proteins, 
receptors and ion channels. The activation of cyclooxygenases (COX), 
phospholipase A2 (PLA2) and lipoxygenases (LOX) is a potential trigger of 
enzymatic dysregulation of the AA pathway![73-75]. Further, it has been suggested 
that activation of COX, PLA2 and LOX occurs in different neuronal disorders for 
example after glutamate challenge suggesting a link between glutamate-induced 
oxidative stress and disruption of the AA cascade [22, 76].  
On the other hand, ROS generated by these enzymes leads to further non-
enzymatic peroxidation of arachidonic acid and of docosahexaenoic acid (DHA), 
which is known to cause formation of 4-hydroxynonenal (4-HNE). This and other 
reactive aldehydes can accelerate neuronal cell death through their ability to modify 
biomolecules [76, 77][78, 79]. 
However, the potential role of a disturbed AA cascade in neurodegeneration is still 
unknown. For this reason this thesis analyzed the role of COX and LOX in neuronal 
oxytosis in further detail in order to explore the detailed mechanisms of formation 






Figure 2: The arachidonic acid metabolism leading to oxidative stress (modified from 
Phillis et al, 2006). Phosphatidylcholine is metabolized by cytosolic phospholipase A2 
(cPLA2) to arachidonic acid (AA). AA can be metabolized by different enzymes such as 
cyclooxygenase (COX) or lipoxygenases (LOX). Alternatively, AA is metabolized non-
enzymatically and forms toxic aldehydes such as 4-hydroxynonenal (4-HNE). The 
metabolites can induce inflammation and oxidative stress causing the formation of reactive 
oxygen species (ROS). In addition, the enzymes have an executionary role in the induction 
of oxidative stress forming ROS by metabolizing their substrates. 
 
Lipoxygenases are iron-containing dioxygenases, which can insert molecular 
oxygen into AA. They have a molecular mass of 75 to 78 kDa and consist of one 
polypeptide chain that is folded into two domains [80, 81]. Lipoxygenases are 
named by the position at which they oxidize AA and by the stereo-configuration of 
their resulting products [82]. Three different forms of LOX can be found in the brain: 
5-LOX, 12-LOX and 15-LOX and 12-LOX was found to be the most common in 
neuronal tissues [83].  
12-LOX was studied most intensively in rat brain where it generates mainly 12-
hydroxyeicosatetraenoic acid (12-HETE) and to some degree 15-HETE [84]. It has 
been postulated that 12-LOX consists of at least two isoforms, which show different 
properties regarding substrate specificity, immunological properties and catalytic 
activity. These two isoforms are often referred to as ‘leukocyte-type’ and ‘platelet-




leukocytes and human or bovine platelets, respectively [84, 85]. ‘Leukocyte-type 12-
LOX’ is the isoform expressed and studied in neurons and is often referred to as 
12/15-LOX because it generates mainly 12-hydroxyeicosatetraenoic acid (12-
HETE) and to some degree 15-HETE [84, 85]. Murine 12/15-LOX has the highest 
degree of identity with the human 15-LOX showing that the murine 12/15-LOX is a 
suitable model to study the role of lipoxygenases in neurodegeneration [84]. 
Previous studies on the role of LOX in the brain suggested that LOX and their 
products are modulators of synaptic function in the nervous system. These studies 
focused on the role of neuronal 12-LOX (12/15-LOX) and concluded that 12/15-LOX 
metabolites might influence long-term-potentiation (LTP) and long-term-depression 
(LTD) in the hippocampus. For example, 12-HETE and 12-
hydroperoxyeicosatetraenoic acid (12-HPETE) both mediated K+-stimulated 
glutamate release from synaptosomes in the hippocampus [86]. Furthermore, 
glutamate induced the formation of 12-HETE in cerebral cortical slices [87]. Others 
analyzed the role of the 12/15-LOX pathway for the induction of LTD and LTP in the 
brain in further detail and concluded that 12/15-LOX activation is required for 
induction of LTD but not for LTP after the activation of metabotropic-glutamate-
receptor [88]. These previous results suggested that 12(s)-HPETE is a potential 
messenger molecule that is involved in the induction of metabotropic glutamate-
receptor dependent LTD thereby demonstrating an important role of LOX for 
physiological neuronal functions in the brain. Taken together, 12/15-LOX have been 
shown to mediate physiological as well as pathological functions in the brain but 
there is still not much known about the role of 12/15-LOX in oxidative-stress 
induced apoptosis. 
 
In addition, some studies analyzed the role of 5-LOX in the brain. For instance, it 
has been shown that 5-LOX is present in the cytosol of neuronal cells and can 
translocate to the nuclear envelope. Further studies suggested a link between the 
expression of glucocorticoids and the stability of 5-LOX in the brain and postulated 
an interaction of 5-LOX with the growth-factor-receptor-bound-protein 2 (Grb2) [89-
91]. The activation of 5-LOX has also been linked to anxiety- and depression-like 
behaviors [92] indicating a link of 5-LOX and their metabolites to neurotransmitter 
signaling in the brain. The role of 5-LOX in acute brain damage has also been 




showing that 5-LOX activation does not mediate neuronal damage after ischemic 
brain injury [93]. Even though these results suggested different neuronal functions 
of 5-LOX the role of 5-LOX in neuronal oxytosis has not been investigated. 
 
The induction of excitotoxicity is known to play a key role in neuronal cell death and 
induces the metabolism of arachidonic acid and thereby the activation of several 
enzymes such as LOX, COX, EPOX and PLA2 [94-96]. In accordance with this 
notion, levels of COX-2 and 5-LOX increase in rat brains after kainate injections 
[97], which can be significantly reduced by COX- and 5-LOX inhibitors [98, 99]. In 
addition, COX-1 activation contributes to prostaglandin synthesis and ROS 
production in models of excitotoxicity [100].  
These previous studies suggested that the metabolism of AA and DHA is important 
in neurodegeneration and that COX and LOX are key mediators of oxidative stress 
in neurons but the detailed mechanisms are still unknown. Consequently, a more 
detailed understanding of COX- and LOX-mediated processes in the brain is 
necessary and therefore part of this thesis.  
 
 
1.4. NO-toxicity in neurodegeneration 
!
Different isoforms of nitric oxide synthase (NOS) produce nitric oxide (NO) from L-
arginine. NO is an important messenger and mediates different physiologic actions. 
It is a neurotransmitter, neuromodulator and also mediates blood vessel dilation. 
However, NO can also form highly reactive and toxic molecules that can react with 
DNA, lipids or proteins and can change their function and thereby cause cellular 
damage [101]. In fact, several studies have implicated NO as a key molecule in 
neurodegeneration for example in Alzheimer’s Disease, Parkinson’s Disease, 
Huntington’s Disease or stroke [102-105]. 
NOS have been identified in all brain cells, in neurons as well as in glia cells [106, 
107]. Three different isoforms have been pointed out: neuronal NOS (nNOS), 
inducible NOS (iNOS) and endothelial NOS (eNOS). All three NOS isoforms are 
expressed in different cell types under different conditions! [107]. In addition, a 




Neuronal NOS is expressed predominantly in neurons, where NO is a key mediator 
of cell communication [107]. In the endothelial tissue of blood vessels eNOS is the 
highest expressed NOS and mediates mainly the relaxation of smooth muscles. 
Pathogen recognition and cytokine release activate iNOS that is expressed 
predominantly in immune cells [109] but also in astrocytes and microglia [107], 
where the produced NO is used to defeat pathogens and to mediate the immune-
like activities of glia cells [107].  
NO has the ability to modify cysteine residues of proteins what is also referred to as 
S-nitrosylation. The S-nitrosylated proteins may enhance neuronal survival. S-
nitrosylation of NMDA receptors (N-methyl-D-aspartate receptors), for example, 
“inactivates” the receptors and therefore inhibits excitotoxicity [110-112]. Caspases 
are also inactivated by S-nitrosylation suggesting that NO-toxicity is not 
predominantly involved in caspase-dependent apoptosis.  
As discussed before, the ability of NO to nitrosylate proteins can mediate cellular 
survival but on the other hand nitrosylation of special proteins induces cell death.  
Additionally, the formation of reactive nitrogen species by reacting with oxygen is an 
important pathologic function of NO.  
A special form of nitrosylation is the 3-nitrotyrosination. When NO reacts with O2-, 
ONOO- is formed, which can react with proteins, especially with tyrosine residues. 
The subsequent change in protein function can mediate cellular death. 
Moreover, NO interferes with excitotoxicity, as mentioned earlier, and thereby can 
mediate neuroprotective effects. The protective effect of NO by blocking NMDA 
receptors depends on the formation of NO+ (nitrosium ion) [101] that S-nitrosylates 
the NMDA-receptor and thereby blocks Ca2+ influx and promotes cell survival. On 
the other hand it is important to note that NO may also mediate excitotoxicity under 
certain conditions [113, 114]. Interestingly, developmental differences seem to 
control if NO mediates neuronal death or neuronal survival. It has been shown, for 
example, that NO mediates neuronal survival in immature hippocampal neurons but 
did not protect mature neurons against NMDA toxicity [115]. How the cells regulate 
the NOS activity in different developmental periods is not yet defined. 
Further, previous studies suggested a link of NO and ONOO- to the mitochondrial 
respiratory chain showing that NO and ONOO- can inhibit complex IV [116-118] and 




An additional mechanism of NO toxicity may be accelerated fission of mitochondria 
[62]. Several studies have shown that a shift in the fusion/fission balance towards 
fission can induce neuronal cell death [63, 122] and it has been discussed that NO 
regulates Drp-1 or mitofusins and therefore mitochondrial dynamics [123, 124]. 
Moreover, others have postulated a role of Zn2+ in NO-induced cell death. Under 
normal conditions Zn2+ is bound to high-affinity ligands, like metallothionein or Zn2+ 
finger-binding proteins but nitrosative stress and even oxidative stress may induce 
the liberation of high amounts of Zn2+ from its stores thereby mediating neuronal cell 
death [125-127]. In addition, it has been shown that Zn2+ increased in the brain after 
ischemia or trauma showing the role of Zn2+ in neurodegeneration.  
In summary, these studies showed that misguided NO formation mediate neuronal 
cell death and postulated several different pathways for NO-mediated toxicity. 
Therefore, this thesis analyzed the role of NO toxicity in HT-22 cells on order to 
investigate the role of NO formation in neuronal oxytosis. 
 
 
1.5. Aims of the thesis 
 
The mechanisms of oxidative stress in neuronal cell death have been matter of 
intense research in the last couple of years, but still the main trigger of ROS 
formation and key mediators of downstream cell death signaling remain poorly 
defined. 
In particular, the role of a disturbed arachidonic acid cascade in neurodegeneration 
has been discussed before [128-130] however, the detailed pathways remain 
unclear. Furthermore, the Bcl-2 proteins and mitochondria have been investigated 
precisely in order to explore their functions in neuronal and non-neuronal cells [2, 
13, 26, 31-33, 131, 132] but up to now the involved pro-apoptotic pathways are still 
a matter of debate. The potential link between the disturbed arachidonic acid 
cascade, the activation of pro-apoptotic Bcl-2 proteins and mitochondrial demise 
after induction of oxidative stress have not been explored. 
Therefore, the investigation of the connection between these important mechanisms 




upstream triggers of oxytosis and downstream regulators of neuronal death that 
may serve as novel targets for neuroprotective strategies.  
 
Previous studies suggested a major role of 12/15-lipoxygenases in neurons [129, 
133, 134] but did not investigate the potential link to other important mediators of 
programmed cell death. 
Moreover, it was the aim of this study to expand the knowledge of LOX in 
neurodegeneration. This thesis focused especially on the role of 12/15-LOX in 
oxidative stress-induced neuronal cell death and analyzed the link of 12/15-LOX 
activation to upstream as well as to downstream mechanisms.  
To elucidate the particular role of 12/15-LOX the selective inhibitors PD146176 and 
AA861 were applied during the experiments. To verify the results gained from 
experiments relying on the use of inhibitors, 12/15-LOX knockout mice were used 
and the experiments were also expanded to applications in a model of MCAO in 





















2. Materials and methods 
 
2.1. Chemicals and reagents 
 
All standard chemicals, were obtained from Sigma-Aldrich (Taufkirchen, Germany) 
and Carl Roth (Karlsruhe, Germany), if not described otherwise. 
All buffers and solutions were prepared using demineralized, ultrapure water that 
was prepared with the SG Ultra Clear UV plus Reinstwassersystem (VWR, 
Darmstadt, Germany). 
For media and solutions that were used in the cell culture the ultrapure, 
demineralized water was sterilized using a steam autoclave (Systec V-40, Systec 
GmbH, Wettenberg, Germany).  
 
All media and solutions that were used in the cell culture were sterilized by filtration 
using 0.22 !M filter sets (Sarstedt, Nürnbrecht, Germany). 
 
 
2.2. Cell culture materials 
 
Sterile plastic materials for the cell culture were purchased from Greiner (T75 
flasks, 6- and 24- well plates, 96- well plates; Frickenhausen, Germany) and 
Sarstedt (35-mm, 60-mm culture dishes, falcon tubes; Nümbrecht, Germany). The 
E-plates for the impedance measurements were obtained from Roche, Applied 
Science (Penzberg, Germany) and the xCELLigence-System was also provided by 










2.3.1. Cell culture and viability assays  
 
2.3.1.1. Cell culture 
 
HT-22 cells were cultured in Dulbecco’s modified Eagle medium (DMEM, 
Invitrogen, Karlsruhe, Germany) supplemented with 10% heat-inactivated fetal calf 
serum (PAA, Pasching, Austria), 100 U/mL penicillin, 100 !g/mL streptomycin 
(PAA, Pasching, Austria) and 2 mM stable glutamine (PAA, Pasching, Austria).  
The LOX inhibitors PD146176 and AA861 (Sigma-Aldrich, Taufkirchen, Germany) 
were dissolved in dimethylsulfoxid (DMSO, Sigma-Aldrich, Taufkirchen, Germany). 
PD146176 was diluted to a concentration of 50 mM and AA861 to a concentration 
of 10 mM. The stock solutions were stored at -20 °C and diluted with cell culture 
medium prior to each experiment up to final concentrations of 0.5 !M PD146176 
and 0.1 !M AA861.  
As the selectivity of AA861 was repeatedly challenged by reports claiming a cross 
inhibition of 5-LOX, this thesis predominantly focused on PD146176 for most of the 
experiments. 
!
Figure 3: The LOX inhibitors PD146176 and AA861 were used to analyze the role of 
12/15-LOX in ROS-induced neuronal cell death. It has been discussed that AA861 also 
inhibits 5-LOX and is not selective for 12/15-LOX therefore PD146176 was used for most of 
the experiments in this thesis. 
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Diphenyleneiodonium chloride (DPI, Enzo Life Science, Lörrach, Germany) was 
dissolved in DMSO to a concentration of 15.9 mM. This stock solution was stored at 
-20 °C) diluted with DMEM medium to a concentration of 0.1 µM before each 
experiment.  
The 5-LOX inhibitors YS121 and C06 [135, 136] (kind gift of Prof. Dr. Steinhilber, 
Frankfurt, Germany) were dissolved in DMSO to prepare stock solutions and diluted 
with DMEM or EBSS immediately before the experiments. The stock solutions had 
a concentration of 5 mM and were stored at – 20 °C. YS121 was diluted to final 
concentrations of 0.41 !M and 4.1 µM with DMEM and C06 was used in final 
concentrations of 0.065 !M and 0.65 µM.  
A glutamate stock solution was prepared at a concentration of 100 mM by solving 
DL-glutamic acid monohydrate (Sigma-Aldrich, Taufkirchen, Germany) in DMEM. 
The stock solution was stored at -20 °C and diluted with DMEM to concentrations of 
2 - 5 mM immediately before use. These glutamate solutions were used to treat the 
cells and cell viability was evaluated 12 - 18 h later.  
For treatment with hydrogen peroxide (H2O2, Sigma-Aldrich, Taufkirchen, Germany) 
H2O2 (stock with a concentration of 30%) was diluted with DMEM to concentrations 
of 500 – 700 µM. The solutions were always prepared immediately before use.  
Sodium nitroprusside (Sigma-Aldrich, Taufkirchen, Germany) was dissolved in 
DMEM immediately before the treatment of the cells and diluted to concentrations 
of 20 – 400 µM.  
Glucose oxidase (Sigma-Aldrich, Taufkirchen, Germany) has been used to achieve 
a continuous production of H2O2. For treating the cells glucose oxidase was 
dissolved in sodium acetate solution (50 mM, pH 5.1, Merck, Darmstadt, Germany) 
and diluted to concentrations of 10 – 20 mU.  
DEANONOate (Enzo Life Science, Lörrach, Germany) was dissolved in Ethanol 
96% (Sigma-Aldrich, Taufkirchen, Germany) to a concentration of 100 mM and 
stored at -20 °C for at most 1 week. This stock solution was diluted to 
concentrations of 500 µM – 2 mM in DMEM immediately before the treatment.  
For induction of oxidative stress through Fe2+ toxicity iron (II) sulfate heptahydrate 
(Sigma-Aldrich, Taufkirchen, Germany) was dissolved in DMEM to concentrations 
of 2 mM, 5 mM and 7.5 mM. The Fe(II) salt solutions were prepared immediately 
before the treatment.  
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The eNOS and nNOS inhibitor N"-Nitro-L-arginine (L-NNA, Sigma-Aldrich, 
Taufkirchen, Germany) was dissolved in 1M hydrochloric acid (HCl, Sigma-Aldrich, 
Taufkirchen, Germany) and diluted to concentrations up to 1 mM with DMEM.  
The antioxidant N-acetyl-L-cysteine (NAC, Sigma-Aldrich, Taufkirchen, Germany) 
was dissolved in DMEM to concentrations of 5 – 20 mM. The solutions were 
prepared freshly before use and the pH was adjusted to 7.2 by addition of sodium 
hydroxide solution (NaOH, Sigma-Aldrich, Taufkirchen, Germany). It is important to 
note that NAC reacts with MTT (see below) and has to be washed away before the 
evaluation of cell viability using the MTT assay. 
L-ascorbic acid (Sigma-Aldrich, Taufkirchen, Germany) was dissolved in DMEM to 
obtain solutions of 0.5 and 1 mM. The solutions were prepared immediately before 
the experiments  
The calcium chelator ethylenediaminetetraacetic acid (EDTA, Sigma-Aldrich, 
Taufkirchen, Germany) was dissolved in water to obtain a stock solution and used 
in final concentrations of 200 µM to 1 mM. 1,2-Bis(2-Aminophenoxy)ethane-
N,N,N!,N!-tetraacetic acid (BAPTA-AM, Sigma-Aldrich, Taufkirchen, Germany) was 
dissolved in DMSO to obtain a stock solution at a concentration of 10 mM and used 
at final concentrations of 10 and 20 µM.  
The mitochondrial complex I inhibitor rotenone (Sigma-Aldrich, Taufkirchen, 
Germany) was added in final concentrations of 10 – 100 µM in DMEM. A stock 
solution of rotenone (100 mM in DMSO) was prepared and stored at -20 °C.  
4-Hydroxynonenal-dimethylacetal, (HNE, Sigma-Aldrich, Taufkirchen, Germany) 
was dissolved in 1 mM cold HCl according to the manufacturer’s protocol and 
diluted to concentrations of 5 – 30 µM with DMEM.  
In order to analyze the toxicity of the used solvents of the different inhibitor, the cells 
were treated with medium containing the highest concentration of the solvent, which 
may be present during the experiment. 
 
 
2.3.1.2. Cell viability assays 
 
Quantification of cell viability in HT-22 cells was performed in 96-well plates by 3-
(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction at 0.25 
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mg/ml for 1.5 h at 37 °C. The reaction was terminated by removing the media and 
freezing the plate at -80 °C for at least 1 h. Absorbance was then determined after 
solving MTT dye in DMSO at 570 nm versus 630 nm (FluoStar, BMG Labtech, 
Offenburg, Germany).  
 
In addition, real time detection of cellular viability was performed by measurements 
of cellular impedance by using the xCELLigence system (Roche Applied Science, 
Penzberg, Germany). The HT-22 cells were seeded in 96 well E-plates (Roche, 
Applied Science, Penzberg, Germany) whose well bottoms are covered with gold 
electrodes. The presence of the cells on top of the electrodes induces an increase 
in the impedance. The more cells are attached on the electrodes, the larger the 
increases in impedance. The system allows to calculate the so-called “cell index” 
that increases when the cells attach to the electrodes. Thus, the Roche 
xCELLigence system detects cellular growth, cellular survival and death, and 
especially the kinetics of these processes during the experiments. The results are 
presented as a curve showing the cell index as a function of time. It is important to 
note that the system is very sensitive to changes in temperature and, therefore, the 
medium was never removed completely for treatments to prevent a persistent 
breakdown of the impedance [Real-time detection of neuronal cell death by 
impedance-based analysis using the xCELLigence System.; Sebastian Diemert, 
Julia Grohm, Svenja Tobaben, Amalia Dolga, Carsten Culmsee, Application note for 
Roche Applied Science, 2010 Aug] 
 
For annexin-V/propidium iodide-staining, HT-22 cells were cultured in 24-well plates 
and challenged with glutamate (3 and 5mM). The cells were harvested 12-15 hours 
after the onset of the glutamate treatment by using Trypsin/EDTA, washed once in 
PBS and resuspended in binding buffer (PromoKine, Heidelberg, Germany). Then 1 
!l/100 !l of propidium iodide and annexin-V-FITC solutions (PromoKine Annexin V-
FITC Detection Kit) were added respectively, and incubated for 5 minutes at room 
temperature. Apoptotic and necrotic cells were detected using a FACScan (Becton, 
Dickinson and Company, Heidelberg, Germany). Annexin-V and propidium iodode 
fluorescence were exited at a wavelength of 488 nm. Emissions were detected at 




2.3.2. Embryonic cortical cultures 
 
Cortices were removed from embryonic day 16 Sprague-Dawley rats (Janvier, Le 
Genest St Isle, France), wild type or Alox15-mice (Jackson Laboratory, Bar Harbor, 
Maine, USA) and dissociated by trypsinization and trituation as followed: Isolated 
cortices were incubated in Hank’s balanced salt solution (HBSS, diluted from 10x 
HBSS, Invitrogen, Karlsruhe, Germany) containing 1 mg/ml trypsin (Sigma-Aldrich, 
Taufkirchen, Germany) for 15 minutes at 37°C. The cortices were then washed with 
HBSS and mixed with HBSS containing 1 mg/ml trypsin inhibitor (Sigma-Aldrich, 
Taufkirchen, Germany) and the cell suspension was incubated for further 2 minutes 
at room temperature. Afterwards, the cortices were washed two times with HBSS, 
and triturated in MEM+ obtained from Eagle’s minimum essential medium 
(Invitrogen, Germany) by addition of 1 mM HEPES (Biomol, Hamburg, Germany), 
26 mM NaHCO3, 40 mM glucose, 20 mM KCl, 1.2 mM L-glutamine (each Sigma-
Aldrich, Taufkirchen, Germany), 1 mM sodium pyruvate (Biochrom, Berlin, 
Germany), 10% (v/v) fetal calf serum (FCS) (Invitrogen, Karlsruhe, Germany) and 
10 mg/l gentamicin sulfate (Sigma-Aldrich, Taufkirchen, Germany).  
Cells were seeded in 35-mm culture dishes coated with polyethylenimine (Sigma-
Aldrich, Taufkirchen, Germany). After 4 hours the MEM+ was replaced by 
Neurobasal medium (Invitrogen, Karlsruhe, Germany).  
Cells were treated 6 days after preparation with 20 !M of glutamate in Earl’s 
balance salt solution (EBSS, diluted from 10 x EBSS, add 2.2 g/l Sodium 
hydrocarbonate, both Sigma-Aldrich, Taufkirchen, Germany). Before adding 
glutamate the cells were washed once with EBSS in order to completely remove the 
Neurobasal medium. 
After 18 to 24 hours the neurons were fixed with paraformaldehyde (4 % in PBS, 
Sigma-Aldrich, Taufkirchen, Germany) and stained with the fluorescent DNA-
binding dye 4’, 6-diamidino-2-phenylindole dihydrochloride (DAPI) (Sigma-Aldrich, 
Taufkirchen, Germany). The percentage of pyknotic nuclei was quantified from 
pictures obtained with a fluorescence microscope (DMI 6000 B, Leica, Wetzlar, 
Germany) connected to a CCD camera (DFC 360 FX, Leica, Wetzlar, Germany) 
without knowledge of the treatment history. For this quantification, at least 200 cells 
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were analyzed from 5 areas per cell culture dish, and experiments were performed 
at least 3 times with n=5 per treatment condition.  
 
 
2.3.3. Plasmids and gene transfer 
 
Plasmid pCDNA 3.1+ was obtained from Invitrogen (Karlsruhe, Germany). The tBid 
vector and control vectors were generated as previously described [137]. The 
mitoGFP vector was a kind gift from Andreas Reichert (Frankfurt, Germany). For 
plasmid transfections 8 x 104 HT-22 cells were seeded in 24-well plates. Antibiotic 
containing growth medium was removed and replaced with 900 !l antibiotic-free 
growth medium. Lipofectamine 2000 (Invitrogen, Karlsruhe, Germany) and ptBID 
plasmid, mitoGFP plasmid or empty vector pCDNA 3.1+ were dissolved separately 
in Optimem I (Invitrogen, Karlsruhe, Germany). The Lipofectamine 2000 solution 
was vortexed for 2 min. After 10 min of incubation at room temperature each DNA 
solution was combined with the respective volume of the Lipofectamine solution, 
mixed gently, and allowed to form DNA plasmid liposomes for further 20 min at 
room temperature. The liposome transfection mixture was added to the antibiotic-
free cell culture medium to a final concentration of 1!g DNA, and 1.5 !l/ml 
Lipofectamine 2000 in HT-22 cells. Controls were treated with 100 !l/ml Optimem 
only, and vehicle controls with 1.5 !l/ml Lipofectamine 2000. 
 
 
2.3.4. Detection of oxidative stress 
 
Intracellular reactive oxygen species (ROS) were detected by 
dichlorodihydrofluoresceine-diacetate (DCF, Invitrogen, Karlsruhe, Germany). 
Within 6 - 17 h after glutamate treatment HT-22 cells were loaded with 1 !M CM-
DCF (Invitrogen, Karlsruhe, Germany) for 30 min and DCF fluorescence was 
monitored using a CyanTM MLE flow cytometer (DakoCytomation, Copenhagen, 
Denmark) at an excitation wavelength of 488 nm and an emission wavelength of 
530 nm.  
"#$%&'#()!*!"%$+,-)!!!!!!05!
!
For detection of cellular lipid peroxidation, cells were loaded with 2 !M BODIPY 
581/591 C11 (Invitrogen, Karlsruhe, Germany) for 60 min in standard medium 6 – 
17 h after glutamate treatment. The supernatants were collected in order to include 
also the already detached cells into the measurements. The attached cells were 
collected after incubating with 1x Trypsin-EDTA (TE) for 3 minutes. After detaching 
of the HT-22 neurons TE reaction was stopped by adding 1000 µl serum-containing 
medium to each well, the cells were collected, and transferred to their respective 
supernatant. Cells were then centrifuged at 1000 rpm, supernatants were removed, 
the pellets washed once in PBS, centrifuged and resuspended in 500 µl PBS and 
then kept on ice until the measurement. Flow cytometry was performed using 488 
nm UV line argon laser for excitation and BODIPY emission was recorded on 
channels FL1 at 530 nm (green) and FL2 at 585 nm (red). Data were collected from 
at least 20000 cells per treatment condition. Lipid peroxides induce a shift from red 
to green fluorescence that can be detected by flow cytometry (Becton, Dickinson 
and Company, Heidelberg, Germany). 
 
 
2.3.5. Detection of the mitochondrial membrane potential 
 
To detect the mitochondrial membrane potential in HT-22 cells the MitoProbe™ JC-
1 Assay Kit - for flow cytometry was used (Invitrogen, Karlsruhe, Deutschland). This 
assay contains 5, 5', 6, 6'- tetrachloro-1, 1', 3, 3'-tetraethyl-benzimidazolyl-
carbocyanine iodide (JC-1). HT-22 cells were stained with JC-1 according to the 
manufacturer’s protocol and analyzed by subsequent flow cytometry. After 
glutamate challenge (12 hours), JC-1 was added at a final concentration of 2 µM. 
Living-control cells were left untreated and damage-control cells were treated with 
carbonyl cyanide m-chlorophenylhydrazone (final concentration of 50 !M) (CCCP, 
included in the MitoProbe™ JC-1 Assay Kit) 5 minutes before staining to induce 
mitochondrial membrane depolarization. The supernatants were collected in order 
to include also the already detached cells into the measurements. The attached 
cells were collected after incubating with 1x Trypsin-EDTA (TE) for 3 minutes. After 
detaching of the HT-22 neurons TE reaction was stopped by adding 1000 µl serum-
containing medium to each well, the cells were collected, and transferred to their 
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respective supernatants. Cells were then centrifuged at 1000 rpm, supernatants 
were removed, and the pellets were washed once in PBS, centrifuged and 
resuspended in 500 µl PBS and then kept on ice until the measurement. 
Mitochondrial membrane potential was determined using the JC-1 fluorophore 
(Invitrogen, Karlsruhe, Germany) and FACScan analysis (Becton, Dickinson and 
Company, Heidelberg, Germany). JC-1 green fluorescence was excited at 488 nm 
and emission was detected using a 530±40 nm filter. JC-1 red fluorescence was 
excited at 488 nm and emission was detected using a 613±20 nm filter. Equal 
loading of the cells with JC-1 dye was detected by the green fluorescence. Living 
cells with intact mitochondria are able to accumulate and reduce JC-1, which is then 
detected by the red fluorescence. 
 
 
2.3.6. Detection of ATP levels 
 
HT-22 cells were seeded in white 96 well plates (Greiner bio one, Frickenhausen, 
Germany) for luminescence measurements. Twenty-four hours after seeding the 
cells were damaged with glutamate (3 - 5 mM). DPI and PD146176 were added one 
hour before glutamate treatment. ATP levels were detected at 3 –18 hours after the 
onset of glutamate exposure by detection of luminescence using the ViaLight MDA 
Plus-Kit (Lonza, Verviers, Belgium). The cells were treated first with a “ Nucleotide 
releasing reagent” (100 !l/well) and incubated for 5 min at room temperature. 
Afterwards the “ATP monitoring reagent” was injected into each well (20 !l/well) and 
luminescence was detected immediately (FluoStar, BMG Labtech, Offenburg, 
Germany). The emitted light intensity was measured for quantification of ATP 
levels. 
The method uses an enzyme called luciferase, which catalyzes the following 
reaction: 
 







For immunocytochemistry HT-22 cells were fixed with 4% PFA. The cells were 
permeabilized with 0.4% Triton X-100 (Sigma-Aldrich, Taufkirchen, Germany) in 
PBS for 5 minutes at room temperature. Cells were then incubated in blocking 
solution (3% horse serum in PBS, PAA, Pasching, Austria) for 30 min and then 
exposed to a polyclonal anti-AIF antibody (1:100 in blocking solution) overnight at 
4°C. This was followed by incubation for 1 h with biotinylated anti-goat IgG antibody 
and 30 minutes in the presence of streptavidin oregon green 514 conjugate 
(Invitrogen, Karlsruhe, Germany) according to the manufacturers protocol. The 
specificity of AIF immunoreactivity was controlled by omission of the primary 
antibody. Nuclei were counterstained with DAPI. Images were acquired using a 
fluorescence microscope (DMI 6000 B, Leica, Wetzlar, Germany) connected to a 





HT-22 cells were treated as described above. Nuclear extracts were obtained by 
using a nuclear extraction kit (Active Motif, Rixensart, Belgium). For the extraction 
HT-22 cells were seeded in 75 cm2 cell culture flasks (1 million cells/flask). In order 
to obtain good amounts of protein in the nuclear fractions 3 flasks were used for 
each treatment condition. The cells were pretreated with PD146176 (0.5 !M) for 1 h 
before adding glutamate. Twelve hours after the exposure to glutamate the 
extraction was started according to the manufacturers protocol. It is important to 
note that the purity of the extracts improved significantly when the nuclei were 
washed 1 time with PBS or hypotonic buffer before the addition of the complete 
lysis buffer. 
For total cell protein extracts HT-22 cells were seeded in 24 well culture plates. At 
least 4 wells per condition were pooled. Cells were washed in PBS and lysed with 





Protein lysis buffer:   Mannitol 0.25 M 
Tris 0.05 M  
EDTA 1M  
EGTA 1M,  
these components were mixed and 
adjusted to pH 7.8 with HCl 1M, this mixture 
can be stored at -20 °C 
 
DTT 1mM  
Triton-X 1% 
1 tablet Complete Mini protease inhibitor 
cocktail per 10 ml (Roche Applied Science, 
Penzberg, Germany),  
these components were added to the 
mixture immediately before use 
 
Protein extracts were kept on ice. To remove insoluble membrane fragments, 
extracts were centrifuged at 15,000 x g for 15 min at 4° C. The supernatants were 
stored at -80° C until further use.  
The protein concentrations of the different extracts were determined by BCA-assay 
(Perbio Science, Bonn, Germany). 5 !l of each protein extract and of protein 
standard solutions was mixed with 200 !l of the BCA-solution and heated at 60 °C 
for 30 minutes. Then 100 !l of each probe was used to measure the absorption at 
562 nm in a 96 well-plate with a plate reader (FluoStar, BMG Labtech, Offenburg, 
Germany). The protein concentration of the probes was calculated in relation to the 
protein standards by linear regression. 
 
For gel electrophoresis and western blot analysis, the following solutions were 
used:  
 For the preparation of Polyacrylamide gels: 
 
0.5 M Tris:   7.88 g Tris-HCl  





1.5 M Tris:   23.6 g Tris-HCl  
in 100 ml water, adjusted to pH 8.8 by 
concentrated HCl 
 
10 % APS:   1 g Ammoniumpersulfate (APS) in 10 ml water 
10 % SDS:  10 g Sodium dodecyl sulfate (SDS) in 10 ml water 
 
In addition to these solutions, N,N,N",N"-Tetramethylethylenediamine (TEMED, 
Promega, Mannheim, Germany) and ultrapure, demineralized water were used to 
prepare the Polyacrylamide gels. The 0.5 M Tris solution was used for the loading 
gels whereas the 1.5 M Tris buffer was used for the preparation of the separating 
gels. It is important to note that the addition of APS and TEMED induces the 
polymerization of the gels. 
 
For the gel electrophoresis the following buffers were used: 
 
Electrophoresis buffer:   3.0 g Trizma base      
      14.4 g Glycine  
1 g SDS in 1000 ml water  
 
 Loading buffer:   7 ml 1M Tris-HCl pH 6,8 
      3 ml Glycerol 
      1 g SDS 
      0.93 g DTT 
      100 µl β-Mercaptoethanol 
      1.2 mg Bromophenol blue sodium salt 
 
For Western blot analysis the following buffers were used: 
 
Transfer buffer:    3.0 g Trizma base  
14.4 g Glycine  




TBST:     2.42 g Trizma base  
29.2 g Sodium chloride  
0.5 ml Tween 20 ad 1000 ml water 
 
 Blocking buffer:   5 g Non-fatty milk powder 
      In 100 ml TBST 
 
 Stripping buffer:   15 g Glycine 
      1 g SDS 
      10 ml Tween 20 
ad 1 l water, adjusted to pH 2.2 by 
concentrated HCl 
 
Discontinuous polyacrylamid gels (separating gel 10% or 15% polyacrylamid, 
loading gel 3.5% polyacrylamid) were cast using the Mini-Protean 3 cell with 1.0 
mm spacer and 10-pocket combs (Bio-RAD, Munich, Germany).  
 
The separating gels contained following components:  
2.5 ml 1.5 M Tris  
0.1 ml SDS 10% 
3.34 ml (10%) or 5 ml (15%) 30% Acrylamid/Bis solution 29:1  
0.05 ml 10% APS  
0.01 ml TEMED and ultrapure, demineralized water ad 10 ml 
 
Stacking gels were prepared with  
2.5 ml 0.5 M Tris  
0.1 ml SDS 10%  
1.2 ml (3.5% gel) 30% Acrylamid/Bis solution 29:1  
0.05 ml 10% APS  
0.01 ml TEMED and water ad 10 ml  
 
An amount of 25 µg protein of each sample was filled up to 20 µl with water. 4 µl 
loading buffer were added and heated at 95°C for 5 minutes. Afterwards the 
samples were loaded onto the gels and 10 µl of PageRuler™ Prestained Protein 
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Ladder  (Fermentas, St. Leon-Rot, Germany) was added in one lane to determine 
the size of the detected proteins. Electrophoresis was performed in the Mini-
Protean$ Tetra Cell (Bio-RAD, Munich, Germany) at 60 V for 20 minutes and then 
at 120 V for circa 2 hours in electrophoresis buffer.  
After electrophoresis, proteins were blotted onto a porablot polyvinylidenfluorid 
membrane (PVDF, Bio-RAD, Munich, Germany) according to the Bio-Rad protocol 
at 15 V for 35 – 50 minutes (depending on the size of the proteins that should be 
analyzed). Blotting was performed in a Trans-Blot SD semi-dry transfer cell (Bio-
Rad, Munich, Germany) using methanol-containing transfer buffer. The blots were 
washed with TBST and blocked for 1 hour in blocking buffer (5% non-fat dry milk-
powder in TBST). 
Briefly, the blot was probed with an anti-AIF goat polyclonal antibody (sc-9416, 1 : 
1000, Santa Cruz Biotechnology, Santa Cruz, CA, USA) or anti-nitro-tyrosin 
antibody at 4°C overnight. Membranes were then exposed to the appropriate HRP-
conjugated rabbit anti-goat secondary antibody (1:2500, Vector Laboratories, 
Burlingame, CA, USA) or anti-rabbit secondary antibody (1:2500, Vector 
Laboratories, Burlingame, CA, USA) respectively, followed by a chemiluminescence 
detection of antibody binding using the Molecular Imager ChemiDoc ® XRS System 
(Bio – Rad, Munich, Germany). Equal protein loading and purity of the extracts was 
controlled by re-probing the membrane with a monoclonal anti-#-tubulin antibody 
(T9026, 1 : 20 000, Sigma-Aldrich, Taufkirchen, Germany) and an anti-HDAC1 
antibody (dianova, Hamburg, Germany 1 : 1000), respectively. For total cell lysates 
an anti-actin antibody (MP Biomedicals, Illkirch, France) was used to control for 
equal loading. ChemiDoc ® software (Bio – Rad, Munich, Germany) was used for 
quantification of western blot signals. 
 
 
2.3.9. Calcium measurements 
 
Calcium levels in primary cortical neurons were detected with the fluorescence dyes 
Fura-2 and Fluo-4-AM.  
For single cell measurement primary cortical neurons were plated on cover slips at 
a density of 3 x 104 cells/cm2. On day 6 after the preparation cells were treated with 
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PD146176 (0.5 !M, 1 h pretreatment) and stained with fura-2 acetoxymethyl ester 
(5 µM) (Invitrogen, Karlsruhe, Germany) for 1 hour at 37 °C. The neurons were 
analyzed using a Polychrome II monochromator and an IMAGO CCD camera (Till 
Photonics, Martinsried, Germany) coupled to an inverted microscope (IX70; 
Olympus, Hamburg, Germany) at 340 and 380 nm for measuring [Ca2+]i. The cover 
slips were fixed on the microscope and then glutamate (20 !M) was added. The 
measurements were started before adding glutamate in order to detect the fast 
increases in intracellular calcium immediately after the exposure to glutamate. This 
method allows the simultaneous detection of increased [Ca2+]i levels in marked 
single neurons. 
In order to analyze a higher number of cells, primary cortical cultures were seeded 
in 96 well plates at a density of 16 x 104 cells/cm2. On day 6 after the preparation 
the cells were pretreated with PD146176 (0.5 !M) and stained with Fluo-4AM (5 !M 
in DMSO) (Invitrogen, Karlsruhe, Germany) for 1 hour at 37 °C. Pluronic% F-127 
(0.02 % in the final solution, Invitrogen, Karlsruhe, Germany) and probenecid (2.5 
mM) were added according to the manufacturer’s protocol (Invitrogen, Karlsruhe, 
Germany) in order to allow penetration of the dye into the cell and to prevent 
leakage of the dye after the staining. After one hour the dye was washed away and 
glutamate was added to each well and fluorescence was detected using a plate 
reader at an excitation wavelength of 488 nm and an emission wavelength of 520 
nm (FluoStar, BMG Labtech, Offenburg, Germany). 
 
 
2.3.10. Oxygen glucose deprivation (OGD) 
 
Primary cortical neurons were seeded in 35 mm cell culture dishes at a density of 5 
x 104 cells/cm2. The OGD is an in vitro model for ischemia that is based on the 
application of medium without glucose and the deprivation of oxygen by exposure to 
a mixture of 5 % carbon dioxide CO2 and 95 % nitrogen (N2) in an air-tight chamber. 
The air-tight chamber is located in an incubator to obtain a temperature of 37 °C 
and linked to a gas bottle containing the mixture of 5 % carbon dioxide CO2 and 95 
% N2. The oxygen concentration is controlled with an oxygen sensor (Oxy 3690 MP, 
Greisinger electronic, Regenstauf, Germany) that also regulates the influx of the 
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gas mixture. In order to prevent the desiccation of the dishes, a cup filled with 
ultrapure water was placed in the air-tight chamber (Figure 4). It is important to note 
that all dishes were opened when they were placed in the chamber to make sure 
that no oxygen is left in the surrounding of the probes. 
Validation of the OGD chamber and the protocol was performed using the NMDA 
receptor antagonist MK-801 (Sigma-Aldrich, Taufkirchen, Germany) because it has 
been established that inhibition of the NMDA glutamate receptors significantly 
reduced OGD-induced neuronal death. MK-801 was dissolved in DMSO and a 
stock solution was prepared at a concentration of 100 mM and stored at -20 °C. 
Prior to the experiments the stock solution was diluted to a final concentration of 10 
!M in EBSS. MK-801 was added 1 h before the onset of OGD and was present in 
the medium throughout the experiment.  
The PD146176 groups were pretreated with the 12/15-LOX inhibitor at a final 
concentration of 0.5 µM for one hour and the 12/15-LOX inhibitor was also present 
in the medium during the experiment. Before the induction of OGD all cells were 
washed two times with EBSS without glucose (EBSS w/o glucose) in order to 
completely remove the glucose. 
 
EBSS w/o glucose:  264 mg/l CaCl2 x 2H2O  
400 mg/l KCl 
200 mg/l MgSO4 x 7H2O  
6.8 g/l NaCl 
2.2 g/l NaHCO3 
158 mg/l NaH2PO4 x 2H2O  
10mg/l Phenolred 
in 1 liter ultrapure, demineralized water 
pH 7.2, adjusted with 1 M HCl 
 
The medium was sterilized by filtration using a 0.22 !m filter.  
For OGD the cells were transferred to the air-tight chamber that was filled with 5 % 
carbon dioxide CO2 and 95 % N2 and they were kept in EBSS w/o glucose. The 
cells stayed in the OGD chamber for four hours. The controls were kept in the 
normal incubator with EBSS containing glucose or Neurobasal respectively. After 
four hours of OGD, EBSS medium containing glucose, was added to all dishes and 
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cells stayed in the standard cell culture incubator for another 18 - 24 hours. For 
further analysis of cell death cells were fixed with paraformaldehyde 4 % in PBS 
(PFA 4%) and stained with the fluorescent DNA-binding dye 4’, 6-diamidino-2-
phenylindole dihydrochloride (DAPI) (Sigma-Aldrich, Taufkirchen, Germany). The 
percentage of pyknotic nuclei was quantified using a fluorescence microscope (DMI 
6000 B, Leica, Wetzlar, Germany) connected to a CCD camera (DFC 360 FX, 
Leica, Wetzlar, Germany) without knowledge of the treatment history. At least 200 
cells were analyzed from 5 areas per cell culture dish and experiments were 
performed at least 3 times with n=5 per treatment condition.  
 
!
Figure 4: For oxygen glucose deprivation (OGD) an air-tight chamber was heated up to 
37°C and filled with 5% CO2 and 95% N2. Before the treatment the cells were washed two 
times with EBSS w/o glucose. After 4 hours of OGD the cells were removed from the 
chamber and the medium was changed to EBSS containing glucose. After 20 – 24 h of 
reoxygenation the cells were fixed with PFA 4% and stained with DAPI for the quantification 
of pyknotic nuclei. The 12/15-LOX inhibitors were present in the medium from 1 h before 






2.3.11. Middle cerebral artery occlusion (MCAO) in mice and 
determination of the neuroscore 
 
The MCAO experiments were performed by Uta Mamrak and Nicole Terpolilli 
(Ludwig-Maximilians-Unversität, Munich, Germany). The 12/15-LOX inhibitor was 
injected to C57BL/6 mice in doses of 0.4 and 4 mg/kg body weight prior to the 
induction of MCAO. Transient focal ischemia was induced for 45 min by a silicon-
coated nylon filament that was introduced into the internal carotid artery to occlude 
the middle cerebral artery (MCA). Surgery was performed in deep isoflurane/N2O 
anesthesia with controlled ventilation, and ischemia and reperfusion were verified 
by laser Doppler measurements. The infarct volume was calculated on the basis of 
the histomorphometric data from 11 consecutive sections obtained 24 h after onset 
of ischemia. Statistical analysis was performed using the Mann-Whitney-U-test. 
For determination of the neuroscore the C57BL/6 mice were examined at 1 and 24 
h after reperfusion. The neuroscore is used to analyze the motor activity of the 
mice. The neuroscore was determined by the following criteria: 1) the motor 
function of each leg was rated independently; 2) sensory deficits of the legs and tail 
were rated separately; and 3) the ability to walk on a beam was tested on 1.5- and 




2.4. Statistical analysis 
 
All data are presented as means ± standard deviation (SD). For statistical 
comparisons between two groups Mann-Whitney U-test was used. Multiple 
comparisons were performed by analysis of variance (ANOVA) followed by 
Scheffé's post hoc test. Calculations were performed with the Winstat standard 








3.1. Glutamate induces oxidative stress in HT-22 cells 
 
In HT-22 immortalized mouse hippocampal neurons glutamate induces cell death 
by inhibition of the xC-transporter and subsequent glutathione (GSH) depletion. 
Since glutathione functions as one of the major endogenous radical scavengers in 
the cell, its depletion leads to the accumulation of reactive oxygen species (ROS) 
up to levels that are critical for cell survival.  
It is important to note that sensitivity to glutamate toxicity varies in HT-22 neurons 
depending on density and passage number of the cells. Consequently, in different 
experiments HT-22 cells were treated with varying concentrations of glutamate (2 – 
5 mM) depending on their sensitivity at the time.  
The characterization of glutamate-induced cell death in HT-22 cells showed that the 
cells die in a time- and concentration dependent manner after the glutamate 
challenge (Figure 5a, 5b). Cell death was evaluated using the MTT assay and 
impedance measurements.  
Impedance measurements were based on the xCELLigence system (Roche, 
Applied Science), which allows real time analysis of cell proliferation and cell death 
kinetics. After exposure to glutamate HT-22 neurons round up and detach from the 
well bottom, thus the impedance decreases. Impedance measurements permit the 
detection of kinetic processes while the MTT assay detects one specific endpoint.  
 
A supposed increase of ROS after the glutamate challenge was measured at 
different time points after onset of glutamate treatment using the fluorescent dyes 
DCF and BODIPY followed by FACS analysis. DCF (Dichlorodihydrofluoresceine-
diacetate) is a cell-permeant indicator for reactive oxygen species that is 
nonfluorescent until the acetate groups are removed by intracellular esterases and 
oxidation occurred within the cell.  
DCF was used to detect total ROS levels in HT-22 cell while BODIPY  (BODIPY® 
581⁄591 C11, Invitrogen, Karlsruhe, Germany) detected lipid peroxides formed after 
glutamate treatment in HT-22 cells. 
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The results obtained from cells exposed to glutamate for 6 h, 8 h and 18 h show a 
time-dependent increase in lipid peroxidation after the glutamate challenge (Figure 
5c). It is interesting to note that glutamate induced a first increase of the number of 
cells containing lipid peroxides within 6 – 8 hours after glutamate exposure and a 
more pronounced accumulation of lipid peroxides at 16 – 18 hours after glutamate 
treatment (Figure 5c). Similar to the ROS formation detected with BODIPY, the 
measurements using DCF showed a two-phase increase in oxidative stress, as 
detected by an initial increase in the fluorescent signal within 6 – 8 hours followed 
by a more pronounced increase at 16 - 18 hours after the glutamate challenge 
(Figure 5d).  
In correlation with the survival experiments these data indicate a first increase in 
ROS formation before the onset of detectable cell death and a second strong 





Figure 5: Glutamate leads to a time-dependent damage in HT-22 cells. (a) HT-22 cells 
were seeded in 96 well E-plates with a density of 4500 cells/well. Attaching of cells and cell 
proliferation were observed for 48 h after seeding and for further 24 h after onset of the 
exposure to glutamate (5 mM). Addition of glutamate is indicated by time point “0 h” in the 
graph. Cell death became detectable 9 – 10 h after the onset of the glutamate challenge. 
After initiation of cell death the HT-22 cells died within 3 – 5 h (n=8). (b) HT-22 cells were 
treated with glutamate (5 mM) for 6, 12, 17 and 18 h. Cell viability was detected by the MTT 
assay (n=8). (c) Glutamate induces the production of lipid peroxides. Glutamate treatment 
was performed for 6 – 18 h. After addition of 2 µM BODIPY 581/591 C11 for 60 min, 
fluorescence was quantified by FACS analysis. Following glutamate exposure, a twofold 
increase in the percentage of cells with lipid peroxidation was determined after 6 to 8 h, and 
a second more pronounced increase was detected after 18 h (n=3). (d) Glutamate was 
added to the cells at a concentration of 3 mM. ROS levels were detected by 
Dichlorodihydrofluoresceine-diacetate (DCF) and quantified by FACS analysis (n=3). 





In order to evaluate the importance of the detected ROS accumulation for cell death 
induced by glutamate in the HT-22 neurons the antioxidants N-Acetyl-L-cysteine 
(NAC, 5 – 20 mM), ascorbic acid (0.5 and 1 mM) and Trolox (50 + 100 !M) were 
added together with glutamate (5 mM). Cell viability was determined using the MTT 
assay 15 hours after the glutamate challenge. All antioxidants significantly reduced 
glutamate-induced damage in HT-22 cells (Figure 6a, 6b, 6c). This data further 
supported the proposed role of increased ROS formation in glutamate-mediated cell 
death in the immortalized hippocampal neurons.  
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Figure 6: Antioxidants significantly reduce glutamate toxicity in HT-22 cells. (a - c) 
HT-22 cells were exposed to glutamate (5 mM). The antioxidants L-ascorbic acid (a, 0.5 – 1 
mM), NAC (b, 10 - 20 mM) and Trolox (c, 50 - 100 !M) were added to the cells together 
with glutamate. Cellular survival was determined 16 hours after the glutamate challenge 
using the MTT assay (n=8). All experiments were repeated 3 times and the results are 




3.2. Extracellular calcium contributes to glutamate-induced 
cell death in HT-22 cells 
!
The previous results demonstrate a key role for ROS formation in glutamate-
induced cell death in HT-22 cells.  
In primary neurons calcium dysregulation is known to be a central mechanism 
caused by glutamate exposure. As HT-22 cells do not express ionotropic glutamate 
receptors [138] it was interesting to characterize the HT-22 cell model in further 
detail by analyzing the role of calcium dysregulation in HT-22 cells.  
The cells were treated with glutamate (3 mM) and the calcium chelators 
ethylenediaminetetraacetic acid (EDTA, 200 µM - 1mM) and 1,2-Bis(2-
aminophenoxy)ethane-N,N,N",N"-tetraacetic acid tetrakis(acetoxymethyl ester) 
(BAPTA-AM, 10 + 20 µM). EDTA functions as a chelator of extracellular calcium 
whereas BAPTA-AM preferentially reduces intracellular calcium levels. Both 
calcium chelators were applied together with glutamate and cell viability was 
measured using the MTT assay at 14 – 16 h after the treatment. Interestingly, 
EDTA could significantly reduce glutamate-induced cell death in HT-22 cells 
whereas BAPTA-AM failed to protect the cells but even significantly reduced cell 
viability (Figure 7a, b). The data show that disruption of the calcium homeostasis is 
involved in glutamate toxicity in HT-22 cells. In addition, the results indicate that the 
extracellular calcium is of importance for glutamate toxicity in HT-22 cells whereas 
release of calcium from intracellular stores may be less important for glutamate-
induced cell death. It is also important to note that higher levels of EDTA (2 mM) 
induced cellular death showing that calcium is important for cellular signaling and 
survival. 
The protective effect of EDTA, however, is not as intense as the strong protection of 
antioxidants showing again the key role of ROS formation in glutamate-induced cell 
death. The role of calcium dysregulation in HT-22 cells as demonstrated by these 





Figure 7: Glutamate causes disruption of calcium homeostasis in HT-22 cells. (a) The 
intracellular calcium chelator BAPTA-AM failed to protect HT-22 cells against glutamate 
toxicity (3 mM). (b) EDTA (200 µM) significantly reduced glutamate-induced cell death 
(n=8). All experiments were at least repeated 3 times and all data are provided as mean ± 








3.3. 12/15-lipoxygenases mediates glutamate-induced cell 
death in HT-22 neurons 
 
The measurements of lipid peroxidation using the BODIPY fluorophore indicated 
that the formation of lipid peroxides plays a major role in glutamate-induced death in 
the HT-22 cells. Such formation of lipid peroxides derives from enzymatic and non-
enzymatic processing of membrane lipids and is mediated through formation of 
arachidonic acid (AA), e.g. by phospholipase A2 (PLA2). The later stages of lipid 
peroxide formation may involve different enzymatic pathways since the main 
substrate AA can be metabolized by cyclooxygenases (COX) or lipoxygenases 
(LOX). It is known that 12/15-LOX, 5-LOX and also COX-1 and COX-2 are present 
in the brain [22]. In order to analyze the potential role of COX and LOX in HT-22 
cells, glutamate treatment was combined with different small molecule inhibitors of 
5-LOX, 12/15-LOX and COX-1/2.  
To study the role of COX-1 and COX-2 in HT-22 cells the COX-1/2 inhibitor 
indomethacin (5 – 100 !M) was added together with glutamate. Cell viability was 
detected by the MTT assay at 16 hours after the onset of glutamate exposure. 
Indomethacin failed to protect the HT-22 cells against glutamate toxicity suggesting 
that enhanced COX activity is not the essential source of ROS production and lipid 
peroxidation in HT-22 cells exposed to glutamate (Figure 8a). 
The 5-LOX was also detected in the brain and was found to be involved in different 
mechanisms as for example in inflammatory processes [22]. The selective 5-LOX 
inhibitors YS121 (0.41 !M + 4.1 !M) and C06 (0.065 !M + 0.65 !M) were used to 
test the involvement of 5-LOX in glutamate-induced cell death in HT-22 cells. Both 
inhibitors were added one hour prior to glutamate and 16 hours later cell viability 
was detected using the MTT assay. Both compounds did not provide protection of 
the cells against glutamate challenge (Figure 8b, 8c) indicating that 5-LOX 





Figure 8: Neither COX nor 5-LOX prevent glutamate-induced cell death. HT-22 cells 
were challenged with glutamate (2 – 5 mM). (a) The COX1/2 inhibitor indomethacin (5 !M, 
50 !M and 100 !M) failed to protect the cells against glutamate toxicity. Cell viability was 
detected by MTT assay (n=8). (b + c) The selective 5-LOX inhibitors YS121 (b, 0.41 !M - 
4.1 µM) and CO6 (c, 0.065 !M - 0.65 µM) did not attenuate glutamate induced cell death. 
Cell viability was analyzed using the MTT assay (n=8). All experiments were repeated 3 
times and the results indicate the mean ± S.D.  
 
 
The small molecule inhibitors PD146176 and AA861 inhibit the 12/15-LOX, which is 
known to be the most abundant LOX in the brain. Both inhibitors were added to the 
HT-22 cells at different concentrations one hour before adding glutamate (4 – 5 
mM). The glutamate-induced damage was detected using the MTT assay and also 
by real time impedance measurements and annexin V/propidium iodide (PI) 
staining. The cells were analyzed at 16 hours after the exposure to glutamate 
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according to the different protocols. PD146176 (0.1 - 0.5 !M) significantly reduced 
glutamate toxicity measured by the MTT assay (Figure 9a) and also significantly 
reduced the number of annexin V/PI-positive cells after the glutamate treatment 
(Figure 9b). These findings were supported by the impedance measurements 
showing that 12/15-LOX inhibition by PD146176 prevented the glutamate-induced 
decrease of the cell index (Figure 9c).  
12/15-LOX inhibition by AA861 also prevented glutamate toxicity (Figure 9d) 
confirming the protective effect of 12/15-LOX inhibition in glutamate-induced 
oxidative stress in HT-22 neurons.  
In summary, these results clearly showed that 12/15-LOX inhibitors protected HT-
22 cells against glutamate toxicity whereas neither COX nor 5-LOX were involved in 




Figure 9: 12/15-LOX-inhibitors protect HT-22-cells against glutamate induced cell 
death. (a) The 12/15-LOX inhibitor PD146176 was applied 1 h before exposure to 
glutamate (5 mM) at concentrations of 0.1 and 0.5 µM (n=8). MTT assay was used to 
determine cell viability 18 h after onset of glutamate treatment. (b) PD146176 significantly 
reduced the annexin-V/propidium iodide positive cells compared to glutamate treated cells. 
Cells were pretreated with the 12/15-LOX inhibitor PD146176 (0.5 µM) 1 h before 
glutamate challenge (5 mM). Cells were stained with annexin-V and propidium iodide and 
detected with FACS analysis (n=4). (c) HT-22 cells were seeded in 96 well E-plates with a 
density of 4500 cells/well. Cells were pretreated with PD146176 for 1 h and treated with 
glutamate 5 mM at 24 h after the seeding. The time point of glutamate addition is marked 
as “0 h” in the graph (n=8). (d) The LOX inhibitor AA861 (0.1 - 1 µM) was applied 1 h 
before glutamate treatment at concentrations of 0.1 and 1 µM (n=8). All experiments were 
repeated 3 times and the results indicate the mean ± S.D. * P<0.05, *** P<0.001 compared 
with glutamate-treated cells (ANOVA, Scheffé-test). 
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In order to evaluate the involvement of 12/15-LOX in the formation of ROS after 
exposure to glutamate, lipid peroxidation was measured in HT-22 cells treated with 
the 12/15-LOX inhibitors PD146176 and AA861 prior to glutamate treatment. Two 
different time points (8 h and 17 h) were investigated representing both, the early 
and late stages of the cell death cascade. Owing to the pronounced cellular 
damage occurring at 17 h the cells were unsuitable for FACS analysis at this time 
point when exposed to 3 mM glutamate. Therefore, the concentration used for 
studying the later time point had to be reduced to 2 mM, whereas 3 mM of 
glutamate were used for the 8 h time point. The 12/15-LOX-inhibitors PD146176 
and AA861 prevented the first glutamate-induced increase in lipid peroxidation after 
6 to 8 h (Figure 10a). In addition, 12/15-LOX inhibition significantly attenuated the 
boost of lipid peroxides detected at 17 h after onset of glutamate treatment 
indicating that 12/15-LOX activation is an essential source of ROS production and 
lipid peroxidation in HT-22 cells (Figure 10b). 
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Figure 10: 12/15-LOX inhibitors prevent lipidperoxide formation in HT-cells exposed 
to glutamate. Lipid peroxidation was detected 8 h (a) and up to 17 h (b) after onset of 
glutamate exposure by FACS analysis after staining of the cells with BODIPY C11 (Ex = 
488nm, Em = 530nm, 613nm). The 12/15-LOX inhibitors AA861 (0.1 µM) or PD146176 (0.5 
µM) were added 1 h before the glutamate challenge (2 – 5 mM) (n=3). The experiments 
were repeated 3 times and the results indicate the mean ± S.D. ** P<0.01, *** P<0.001 
compared with glutamate-treated cells (ANOVA, Scheffé-test). 
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Since the previous results suggested a key role of 12/15-LOX in glutamate-induced 
oxidative stress in HT-22 cells, the next steps of the study included a detailed 
analysis of the underlying mechanism. For the potential therapeutic application of 
this principle of neuroprotection the protective time window is of utter importance 
and thus needs to be defined.  
To address this question the 12/15-LOX-inhibitor PD146176 was added at different 
time points between 2 h and 15 h after onset of the glutamate treatment. Cell 
viability was detected by the MTT assay at 17 hours after the exposure to 
glutamate. HT-22 cells were protected against glutamate toxicity even when 
PD146176 was added up to 8 h after the glutamate challenge indicating a 
prolonged therapeutic time window. Nonetheless, beyond that time point glutamate-
induced cell death may have proceeded too far to be rescued by LOX inhibition 
(Figure 11a). Similar results were obtained with the antioxidant Trolox, which also 
proved to be protective up to 8 h after the glutamate challenge (Figure 11b). 
Altogether, these findings stress the significance of ROS in glutamate dependent 
cell death in HT-22 cells and reveal an 8 h time window for protective intervention 
when targeting the 12/15-LOX. In terms of therapeutic feasibility this rather 
prolonged time window of 8 h renders the 12/15-LOX an interesting target to 




Figure 11: Time window of protection against glutamate toxicity for PD146176 and 
Trolox. (a) The 12/15-LOX inhibitor PD146176 protects HT-22-cells when applied up to 8 h 
after glutamate treatment. PD146176 (0.5 !M) was added at time points between 2 and 15 
h after onset of glutamate treatment (5 mM). MTT assay was used to determine cell viability 
18 h after onset of glutamate exposure (n=8). (b) Trolox protects HT-22 cells against 
glutamate toxicity when applied up to 8 h after glutamate challenge. Cells were treated with 
Trolox (50 µM) at time points between 2 and 15 h after glutamate (5 mM) challenge. Cell 
viability was detected by MTT assay (n=8). All experiments were repeated 3 times and the 
results indicate the mean ± S.D. *** P<0.001 compared with glutamate-treated cells 
(ANOVA, Scheffé-test). 
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3.4. 12/15-LOX mediates cell death in primary neurons 
 
In primary neurons glutamate induces excitotoxicity via massive calcium influx 
through NMDA receptors. Consequently, cell death mechanisms are different in 
primary neurons compared to HT-22 cells, since pronounced increases in 
intracellular calcium levels trigger cell death pathways in primary neurons exposed 
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to glutamate, whereas calcium influx plays a minor role for glutamate toxicity in HT-
22 cells. Nevertheless, formation of ROS is a major feature involved in glutamate 
toxicity in primary neurons downstream of initial calcium overload of the cells. 
Therefore, PD146176 was also tested in primary neuronal cultures to examine the 
role of 12/15-LOX activation in this model system of glutamate-induced 
excitotoxicity. 
Primary cortical cultures were treated on day 6 – 10 after the preparation. At this 
time point the neurons express NMDA receptors and are highly sensitive to 
glutamate. 
In primary cortical neurons PD146176 (0.5 - 1 µM) was added 1 h before the 
glutamate exposure (20 µM). Cell viability was evaluated 18 - 24 hours after 
glutamate treatment by DAPI staining of the nuclei and subsequent quantification of 
pyknotic nuclei.  
The 12/15-LOX inhibitors significantly reduced the glutamate-induced cell death in 
primary neuronal cells (Figure 12a).  
 
In addition, primary cortical neurons were prepared from Alox-15 mice (12/15-LOX 
knockout mice, 12/15-LOX is encoded by the Alox15 gene). This genetic approach 
was used to confirm the involvement of 12/15-LOX activity in excitotoxicity thereby 
also validating the previous results obtained with the pharmacological substances. 
Neurons from wild type mice were used as controls in these experiments. Neuronal 
cultures obtained from wt and Alox-15 mice were treated with glutamate (20 !M) on 
day 7 – 10 after the preparation. The cell viability was evaluated by quantification of 
DAPI-stained pyknotic nuclei.  Cortical neuronal cultures from Alox15-mice showed 
significantly reduced cell death after glutamate challenge compared to cells 
obtained from wild type mice (Figure 12b). These results demonstrated that 
activation of 12/15-LOX plays an important role in glutamate induced excitotoxic cell 





Figure 12: 12/15-LOX inhibition protects primary neurons against glutamate-induced 
excitotoxicity. (a) Primary cortical neurons were damaged with glutamate (20 µM) and 
pretreated with PD146176 for 1 h. PD146176 (0.5 !M) significantly reduced glutamate-
induced cell death. (b) Primary cortical neurons obtained from Alox-15 mice and wild type 
neurons were treated with glutamate (20 !M). Alox-15 neurons showed significantly 
reduced damage compared to wild type neurons. All data are provided as mean ± S.D. ** 
P<0.01, compared to glutamate-treated cells and ## P<0.01 compared to glutamate-treated 
wild type neurons (ANOVA, Scheffé test). 
 
 
3.5. 12/15-LOX inhibition prevents calcium dysregulation in 
primary cortical neurons 
 
Excitotoxicity is known to induce cell death after glutamate stimulation of NMDA 
receptors in primary neurons. The addition of glutamate causes a rapid increase in 
intracellular calcium concentration followed by delayed calcium dysregulation with 
fatal consequences for the neuronal cell.  
In order to investigate the effect of 12/15-LOX on glutamate-induced disruption of 
calcium homeostasis in primary neurons, calcium levels were determined in cortical 
neuronal cultures using fluorescence measurements.  
Primary cortical neurons were pretreated with PD146176 (0.5 !M) and stained with 
calcium detecting fluorescence dyes (Fura-2 or Fluo-4 AM) on day 6 after the 
preparation. After adding glutamate the increases in intracellular calcium 
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concentrations were detected by fluorescence measurements. Fluo-4 AM was used 
to measure calcium levels in primary cortical cultures with a plate reader (96 well-
plate, FluoStar, BMG Labtech, Offenburg, Germany). These experiments showed 
that glutamate induced a significant increase in fluorescence intensity, i.e. 
pronounced increases in intracellular calcium levels. PD146176 clearly attenuated 
the glutamate-induced calcium influx in the neuronal cultures suggesting that 12/15-
LOX activation was involved in mechanisms of glutamate-induced excitotoxicity 
(Figure 13a). 
For further analysis single neurons were stained with Fura-2 (5 !M) and analyzed 
with a fluorescence microscope allowing the detection of calcium dysregulation in 
single neurons. Exposure to glutamate caused a fast calcium increase as well as a 
delayed calcium deregulation. Cells pretreated with PD146176 (0.5 !M) before the 
exposure to glutamate, showed significantly reduced intracellular calcium levels 
compared to cells treated with glutamate alone (Figure 13b). 
 
Both methods detected a significantly reduced intracellular calcium increase after 
pretreatment with the 12/15-LOX inhibitor. These data suggest that 12/15-LOX is 
involved in the regulation of the calcium homeostasis in primary neurons exposed to 





Figure 13: PD146176 significantly reduces glutamate-induced disruption of calcium 
homeostasis in primary neurons. (a) Primary cortical neurons were seeded in 96 well-
plates and were stained with Fluo-4 AM for 1 h at 37 °C at day 6 after the preparation. 
Pluronic% F-127 (0.02% in the final solution) and Probenecid (2.5 mM) were added 
according to the manufacturer’s protocol to allow the penetration of the dye into the cells 
and to prevent leakage, respectively. PD146176 (0.5 !M) was added 1 h prior to the 
glutamate treatment. Glutamate (20 !M, final concentration in the well) was injected into 
each well with a plate reader coupled to an injection pump (FluoStar, BMG Labtech, 
Offenburg, Germany). (b) Primary cortical neurons were seeded on cover slips and stained 
with Fura-2 (5 !M) at day 6 after the preparation (1 h at 37 °C). PD146176 (0.5 !M) was 
added 1 h prior to the addition of glutamate (20 !M). Single cells were analyzed with a 
fluorescence microscope detecting the increase of intracellular calcium in single neurons. 




3.6. PD146176 reduces cell death after oxygen glucose 
deprivation in vitro and reduces brain infarction after 
MCAO in vivo 
 
Cerebral ischemia causes severe and persistent brain damage and thus a 
detrimental disease with a high mortality rate. To date, tissue plasminogen activator 
(tPA) is the only available therapy in patients suffering from ischemic stroke. 
However, the number of stroke patients eligible for tPA treatment is very limited for 
safety reasons and, thus, the vast majority of patients do not receive any therapy 
targeting the cause of ischemia or mechanisms of infarct development.  
Oxygen glucose deprivation (OGD) was used here as an in vitro model for cerebral 
ischemia to investigate the role of 12/15-LOX activation in delayed neuronal death. 
In order to validate the OGD model the highly potent and selective non-competitive 
NMDA glutamate receptor antagonist MK-801 (Sigma-Aldrich, Taufkirchen, 
Germany) was used, which is known to reduce neuronal damage after OGD and 
middle cerebral artery occlusion. Primary cortical neurons were treated with MK-801 
(10 !M) 1 hour prior to OGD and were exposed to OGD for 4 hours. After 24 h of 
reperfusion the cells were analyzed by DAPI staining and quantification of pyknotic 
nuclei. MK-801 significantly reduced neuronal damage after OGD showing that the 
OGD protocol is valid (Figure 14a). 
For investigation of the role of 12/15-LOX activation for delayed neuronal death 
after OGD, primary neuronal cultures were treated with PD146176 (0.5 !M) or 
AA861 (0.1 !M) 1 h before deprivation of oxygen and glucose. Cell viability was 
evaluated again by DAPI staining and counting of the pyknotic nuclei at 24 hours 
after reperfusion. 12/15-LOX inhibition significantly reduced cellular death induced 
by OGD in primary neurons indicating that 12/15-LOX activation is involved in 
ischemic neuronal death (Figure 14b).  
This hypothesis was further addressed in a model of transient middle cerebral 
artery occlusion (MCAO) in mice to test the effect of 12/15-LOX inhibition in vivo. 
These experiments were performed by Uta Mamrak und Nicole Terpolilli at the 
Ludwig-Maximilians-Universität, Munich, Germany. The C57BL/6 mice obtained 
intraperitoneal injections of two different doses of PD146176 (0.4 and 4 mg/kg) 1 h 
before the induction of MCAO. The infarct volume in the brains was analyzed 24 
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hours after reperfusion. Pretreatment with PD146176 (4 mg/kg) significantly 
reduced the infarct volume in mouse brains suggesting 12/15-LOX as mediators of 
acute brain damage after MCAO (Figure 14c).  
In addition, the neuroscore was evaluated in the mice at 1 and 24 hours after 
reperfusion. The neuroscore is used to judge about the motor activity of the 
animals. Mice pretreated with PD146176 (4 mg/kg) had a significantly improved 
neuroscore at 1 hour and 24 hours after reperfusion (Figure 14d). These results 
indicate that 12/15-LOX activation also participates in ischemic brain damage and 




Figure 14: PD146176 reduces damage after OGD and MCAO in primary neurons. (a) 
For validation of the OGD model MK-801 (10 !M) was added to primary cortical neurons 1 
hour before the induction of OGD (4 h). MK-801 significantly reduced OGD-induced cell 
death. (b) Primary cortical neurons were exposed to 4 h of OGD. 12/15-LOX inhibition 
(PD146176 0.5 !M, AA861 0.1 !M) significantly reduced cell death compared to controls. 
(a, b) Cell viability was evaluated by DAPI staining and counting of not less than 200 cells 
per sample. The experiments were at least repeated 3 times and all data are provided as 
mean ± S.D. *** P<0.001, ** P<0.01, * P<0.05 compared with glutamate-treated cells 
(ANOVA, Scheffé-test). (c, d) C57BL/6 mice were treated with PD146176 (0.4 mg/kg and 4 
mg/kg) before the induction of MCAO. (c) The infarct area was calculated 24 hours after 
reperfusion. (d) The neuroscore was determined at 1 and 24 hours after reperfusion in 




3.7. The role of 12/15-LOX in different models of oxidative 
stress 
 
The previous results suggested 12/15-LOX activation as key mediator of glutamate-
induced oxidative stress in HT-22 cells as well as in primary neurons.  
Next, the role of 12/15-LOX activation was investigated in other well-accepted 
models of oxidative stress in neurons in order to elucidate, whether LOX activity is a 
general mechanism of neuronal cell death induced by various different oxidative 
stimuli. To this end, several prominent models of oxidative stress were analyzed to 
address the potential involvement of 12/15-LOX activity. HT-22 neurons were 
exposed to radical donors like glucose oxidase (GO) and H2O2 as well as to HNE 
(4-Hydroxynonenal), iron (II) sulfate and nitrogen monoxide (NO)-donors. 
 
 
3.7.1. 12/15-LOX inhibition does not prevent neuronal death 
induced by radical donors 
 
Radical donors are commonly used in models of lethal oxidative stress in neuronal 
cells and were applied in several studies on mechanisms of neurodegenerative 
diseases [139, 140]. On the basis of the previous findings in glutamate toxicity, it 
was interesting to analyze the role of 12/15-LOX activation in other settings of 
oxidative stress. 
The radical donors glucose oxidase (GO) and H2O2 induced concentration- and 
time-dependent cell death in HT-22 cells (Figure 15a, 15b). It is important to note 
that GO induces a continuous release of H2O2 whereas H2O2 causes high levels of 
ROS immediately after the treatment. Therefore, the treatment with GO may be 





Figure 15:!H2O2 and glucose oxidase induce cell death in HT-22 cells. HT-22 cells were 
treated with (a) H2O2 (500 µM – 1 mM) and (b) glucose oxidase (1 – 20 mU/ml). Cell death 
was evaluated by MTT assay at 14 – 16 h after the onset of the treatment (n=8). Cells died 
in a concentration- and time-dependent manner. The experiments were repeated 3 times 
and the results are presented as mean ± S.D.  
!
 
To determine the potential role of 12/15-LOX in GO- and H2O2-induced cell death 
HT-22 cells were pretreated with PD146176 (0.5 µM) for one hour before incubation 
with H2O2 (500 – 700 µM) or glucose oxidase (10 – 20 mU).  Cell viability was 
evaluated using the MTT assay at 14 h after the treatment showing that 12/15-LOX 
inhibition could not prevent cell death induced by radical donors (Figure 16a, 16b).  
Radical scavengers like NAC (5 – 20 mM,) however, protected HT-22 cells against 
H2O2 induced cell death (Figure 16c).  
Overall, these data show that glutamate-induced cell death and the associated 
oxytosis are not comparable with damage induced by radical donors and that 12/15-
LOX activation may not play a major role in cell death of HT-22 cells exposed to 
radical donors.  
In addition, these data confirm previous data [141] showing that PD146176 has no 
antioxidant properties per se, also confirming that the protective effects against 
glutamate toxicity were achieved through its activity as a 12/15-LOX inhibitor and 





Figure 16: 12/15-LOX inhibition does not prevent radical donor-induced cell death.  
(a) H2O2 (500 – 700 !M) and (b) glucose oxidase (10 – 20 mU) were added to HT-22 cells 1 
hour after pretreatment with PD146176 (0.5 µM). After 16 hours cell death was evaluated 
using the MTT assay (n=8). (c) HT-22 cells were treated with the antioxidant NAC (5 + 20 
mM) and H2O2 for 16 hours. Cell viability was detected with the MTT assay (n=8). All 
experiments were repeated 3 times and the results are presented as the mean ± S.D. * 





3.7.2. Iron toxicity is not prevented by 12/15-LOX inhibition 
 
It has been proposed that accumulation of iron (Fe2+) and iron dependent formation 
of ROS through the Fenton reaction, are involved in neuronal cell death in 
neurodegenerative disorders. For example, in Alzheimer’s Disease iron levels are 
increased in the brain and may thus contribute to the increase in ROS levels [142]. 
In order to analyze the role of 12/15-LOX in Fe2+-induced oxidative stress iron 
sulfate solution (2 - 10 mM) was applied to HT-22 cells. The addition of iron sulfate 
induced the formation of Fe2+ and subsequent increase in ROS thereby causing 
time- and concentration-dependent cell death (Figure 17a).  
The radical scavenger N-acetylcysteine (NAC, 5 – 20 mM) was added together with 
iron sulfate whereas PD146176 (0.5 µM) was added 1 hour before the damage with 
iron sulfate (2 – 5 mM). Cell viability was evaluated using the MTT assay. 
Interestingly, neither the antioxidant NAC (Figure 17b) nor the 12/15-LOX inhibitor 
(Figure 17c) protected the HT-22 cells against Fe2+-induced toxicity.  
These results show that cell death induced by Fe2+ is independent of 12/15-LOX 
activation and therefore following different mechanisms than glutamate-induced cell 
death. The fact that also the antioxidant NAC did not prevent iron toxicity indicates 
that iron causes cell death mechanisms that are either independent of ROS 
production or at least cannot be blocked by NAC either. 
In addition, it is important to note that the results obtained with the MTT assay may 
cause the impression that NAC induced cell death itself but regarding the 




Figure 17: Fe2+ toxicity in HT-22 cells is not prevented by NAC or 12/15-LOX 
inhibition. (a) Iron sulfate (2 – 10 mM) induced cell death in HT-22 cells. (b) NAC (10 – 20 
mM) and (c) PD146176 (0.5 !M) failed to prevent Fe2+-induced cell death (n=8). Cell 
viability was detected using the MTT assay at 14 – 16 hours after the exposure to iron 











3.7.3. HNE induced cell death is not prevented by 12/15-LOX 
inhibition 
 
4-Hydroxynonenal (HNE) is a toxic second messenger of free radical formation 
often detected, e.g. in the brain of AD patients, and is therefore also used as a 
model for oxidative stress to investigate mechanisms of in neurodegeneration.  
Peroxidation of cellular membrane lipids or circulating lipoprotein molecules 
generates highly reactive aldehydes among which one of the most important is 4-
hydroxynonenal. HNE levels are elevated in several neurodegenerative diseases 
and application of HNE to neuronal cultures is widely used as a model system of 
oxidative stress in neurodegenerative diseases [76, 143, 144].  
PD146176 was used to investigate the role of 12/15-LOX activation after HNE 
treatment in HT-22 cells. HNE induced concentration- and time- dependent cell 
death in HT-22 neurons (Figure 18a) that could not be reduced by PD146176 (0.5 
!M) (Figure 18b). Cell viability was measured using the MTT assay 14 – 16 hours 
after the exposure to HNE.  
These data suggest that 12/15-LOX is not mediating cell death induced by HNE in 
HT-22 cells. Further, these results indicate that HNE induces different apoptotic 
death pathways than glutamate in these cells, and that glutamate toxicity does not 
involve formation of large amounts of HNE. 
!
Figure 18: 4-hydroxynonenal (HNE) causes damage in HT-22 cells that is 
independent of 12/15-LOX activation. (a) HNE (2 – 10 µM) induced time- and 
concentration- dependent cell death in HT-22 cells (n=8). (b) The inhibition of 12/15-LOX by 
PD146176 (0.5 !M) failed to prevent HNE-induced damage (5 + 10 !M) (n=8). Cell viability 
was detected using the MTT assay. All experiments were repeated 3 times and the results 
are shown as the mean ± S.D. 
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3.7.4. NO toxicity and subsequent nitrosylation of proteins is 
not affected by 12/15-LOX inhibition 
 
Nitrogen monoxide (NO) toxicity has been described to be involved in different 
neurodegenerative processes associated with enhanced oxidative stress [25, 113, 
114, 123, 145]. It has been suggested that NO mediates, for example, the 
nitrosylation of Drp-1 and other proteins thereby inducing cellular death [107, 123, 
124, 146-148]. Therefore, it was interesting to investigate the role of 12/15-LOX 
activation in NO-mediated cellular death in HT-22 neurons.  
Here, the NO-donor DEANONOate (1 - 5 mM) was applied to induce NO toxicity by 
a fast release of NO. It is important to note that DEANONOate is not very stable 
suggesting that after the treatment high NO-levels were present which degraded 
very fast. DEANONOate induced a concentration dependent damage in HT-22 cells 
that was detected by the MTT assay at 14 hours after the onset of the treatment 
with DEANONOate (Figure 19a, 19b). In order to analyze the involvement of 12/15-
LOX in NO-mediated toxicity PD146176 (0.5 µM) was added 1 h prior to 
DEANONOate. Cell death was detected again using the MTT assay 14 hours after 
the DEANONOate challenge. Inhibition of 12/15-LOX failed to prevent cell death 
induced by DEANONOate (Figure 19b) suggesting that NO-induced cell death does 
not involve 12/15-LOX activation in HT-22 cells. 
!
Figure 19: NO toxicity does not involve 12/15-LOX activity. (a) The NO-donor 
DEANONOate (0.5 – 10 mM) reduces cell viability in HT-22 cells in a concentration-
dependent manner. (b) PD146176 (0.5 !M) was added 1 h prior to DEANONOate (2 – 10 
mM). 12/15-LOX inhibition did not prevent DEANONOate-induced cell death (n=8). Cells 
were analyzed using the MTT assay 14 – 16 h after the onset of the treatment. The 
experiment was repeated 3 times. The data are presented as mean ± S.D. 
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In order to examine the role of potential NO release in further detail, the HT-22 cells 
were treated with sodium nitroprusside (SNP) (20 µM – 20 mM), which induces the 
formation of NO and CN-, as well as of Fe2+.  
It is important to note that SNP may cause more persistent low levels of NO and 
also Fe2+ and CN- are continuously released over time in contrast to the addition of 
DEANONOate or iron sulfate, where the toxic agent is immediately available at the 
applied concentration (compare 3.7.2). Cell viability was detected by using the MTT 
assay at 16 hours after SNP application. SNP reduced cell viability in the HT-22 
cells in a concentration- and time-dependent manner (Figure 20a). To determine 
the role of 12/15-LOX after SNP treatment, PD146176 (0.5 !M) was added 1 hour 
prior to SNP. The MTT assay showed that 12/15-LOX inhibition failed to prevent 
SNP toxicity (Figure 20b).  
These results suggest that cell death induced by NO-donors such as DEANONOate 
or SNP activate different apoptotic death pathways than glutamate and that 12/15-
LOX was not involved in NO-mediated cell death in neuronal HT-22 cells. 
 
In order to examine the mechanism of SNP toxicity in further detail total protein 
lysates of HT-22 cells were analyzed by western blotting after exposure to SNP and 
nitrosylation of tyrosine residues was evaluated. The NO-donor DEANONOate was 
used as positive control in order to confirm the function of the antibody. 
Interestingly, tyrosine-nitrosylation was not detectable in cells exposed to SNP 
suggesting that the formation of NO and subsequent tyrosine nitrosylation was not a 
prominent trigger of cell death in HT-22 cells (Figure 20c). Consequently, SNP 
toxicity may be mediated predominantly by CN- or Fe2+ formation or may result from 




Figure 20: 12/15-LOX inhibition does not prevent SNP-induced cell death. (a) SNP (20 
!M – 20 mM) induced death in HT-22 cells in a time- and concentration-dependent manner. 
(b) HT-22 cells were pretreated with PD146176 (0.5 !M) for 1 h. 12/15-LOX inhibition failed 
to prevent SNP-induced cell death (n=8). (c) SNP does not induce detectable nitrosylation 
of tyrosine residues in HT-22 cells. HT-22 cells were treated with SNP (400 - 600 !M) or 
with DEANONOate (2 mM). Total cell lysates were obtained from the damaged cells 16 h 
after the exposure to SNP or DEANONOate and analyzed by western blotting. Nitrosylated 
tyrosine residues were detected using an anti-nitro-tyrosine antibody (New England Biolabs 
GmbH, Heidelberg, Germany). Cell viability (a + b) was detected by the MTT assay at 14 – 
16 h after the exposure to SNP. All experiments were repeated 3 times and the results are 
presented as the mean ± S.D.  
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To find out whether NO toxicity is relevant in glutamate induced cell death and 
contributes to glutamate-induced damage independently of 12/15-LOX activation, 
the NO synthesis was blocked by N"-Nitro-L-arginine (L-NNA). L-NNA is a selective 
inhibitor of the neuronal (nNOS) and the endothelial (eNOS) nitric oxide synthase. 
The HT-22 cells were treated with glutamate (5 mM) and L-NNA (0.01 and 0.1 mM) 
for 16 hours. The cell viability was detected by MTT assay showing that the inhibitor 
of nNOS und eNOS failed to prevent glutamate-induced cell death (Figure 21a). 
These results indicate that NO-toxicity plays a minor role in HT-22 cells after the 
glutamate challenge.  
To confirm that NO formation after the glutamate challenge is less important in HT-
22 cells, total cell lysates were analyzed by western blotting. It is known that NO 
induces the nitrosylation of proteins which may contribute to subsequent apoptotic 
processes. Protein nitrosylation was detected using an antibody against nitrosylated 
tyrosine (New England Biolabs GmbH, Frankfurt am Main, Germany). 
DEANONOate was used as a positive control to confirm that the antibody worked 
properly. The analysis did not show nitrosylation of proteins after glutamate induced 
cell death while DEANONOate induced strong tyrosine nitrosylation (Figure 21b). 
This analysis confirmed the results obtained with the nNOS/eNOS-inhibitor and 





Figure 21: Glutamate does not induce NO-formation in HT-22 cells. (a) HT-22 cells 
were treated with glutamate (5 mM) and the nNOS/eNOS inhibitor L-NNA (0.01, 0.1 mM). 
The nNOS/eNOS inhibitor did not protect the HT-22 cells against glutamate toxicity (n=8). 
Cell viability was evaluated using the MTT assay at 14 – 16 h after the onset of glutamate 
treatment. (b) HT-22 cells were treated with PD146176 (0.5 !M) and glutamate (3 mM). 
The NO-donor DEANONOate (2 + 5 mM) was used as positive control. Total cell lysates of 
the cells were obtained 14 h after the exposure to glutamate and were analyzed by western 
blotting. An antibody against nitro-tyrosine (1:1000 in blocking buffer, New England Biolabs 
GmbH, Frankfurt am Main, Germany) was used to detect tyrosine nitrosylation and an anti-
actin antibody (New England Biolabs GmbH, Frankfurt am Main, Germany) was used as 
loading control (n=3). All experiments were repeated 3 times and the results (a) indicate the 








Overall, the experiments showed that 12/15-LOX activation plays a major role in the 
formation of ROS after glutamate exposure but not in other models of oxidative 
stress including exposure of neurons to radical donors, HNE, NO-donors or iron 
sulfate.  
These results further suggest specific cell death mechanisms of oxytosis triggered 
by glutamate in neurons that involves 12/15-LOX activation. Therefore, this thesis 
further focused on cell death pathways that were involved downstream of 12/15-
LOX activation in neurons exposed to glutamate toxicity.  
 
 
3.8. Inhibition of Bid protects HT-22 neurons against 
glutamate-induced oxidative stress 
 
So far, the results obtained in this thesis demonstrated a major role for 12/15-LOX 
in glutamate-induced lipid peroxidation and cell death. However, it was unclear how 
the 12/15-LOX dependent bi-phasic increase in ROS production was linked to 
downstream signaling pathways of programmed cell death. Very recent reports on 
the role of 12/15-LOX suggested a mitochondrial activity of 12/15-LOX [149] 
indicating that LOX may induce mitochondrial demise directly at the mitochondrial 
membrane. Thus, further investigations in this study focused on the link between 
12/15-LOX and mitochondrial pathways of neuronal cell death in HT-22 cells.  
It is known that mitochondria are important organelles in cell death mechanisms 
because they can release pro-apoptotic proteins and produce large amounts of 
ROS. The protective effect of the 12/15-LOX inhibitors included inhibition of the first 
increase in ROS after the glutamate challenge but failed to protect from further 
damage when applied after 8-10 h, i.e. the time point of the secondary more 
pronounced increase in ROS. This suggested that cell death pathways initially 
triggered by 12/15-LOX activity reached a ‘point of no return’ because other cell 
death messengers and, for example, production of ROS in mitochondria took over 
to execute cell death independent of 12/15-LOX activity. To identify key elements of 
these secondary events and the mode of mitochondrial death pathways were thus 
the next aims.  
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One possible candidate that may link increased ROS production and mitochondrial 
dysfunction in HT-22 cells is the pro-apoptotic Bcl-2 family protein Bid. 
Bid plays an important role in glutamate induced cell death in HT-22 cells [26] and 
also in primary neurons [131, 150]. The selective Bid inhibitor BI-6C9 [151] 
significantly reduced glutamate induced cell death in HT-22 cells (Figure 22) as well 
as in primary neurons [150] and prevented mitochondrial demise [26] suggesting 
Bid as a key molecule in glutamate-induced neuronal cell death. Consequently, the 
following experiments addressed the potential link between Bid and 12/15-LOX in 
glutamate-induced neuronal damage in HT-22 neurons. 
!
Figure 22: Bid inhibition protects HT-22 cells against glutamate-induced cell death. 
HT-22 cells were treated with glutamate (5 mM) and the small molecular Bid inhibitor BI-
6C9 (10 !M). BI-6C9 prevented glutamate-induced cellular death. Cell viability was 
detected by using the MTT assay (n=8). The experiment was repeated 3 times and the 
results are presented as the mean ± S.D. *** P<0.001 compared with glutamate-treated 
cells (ANOVA, Scheffé test). 
 
!
To find out more about the potential link of the Bid protein and the 12/15-LOX, HT-
22 cells were transfected with a vector, which causes the expression of the 
cytotoxic truncated Bid (tBid), which induces cellular death within 24 h. The cells 
were treated with PD146176 (0.5 !M) or AA861 (0.1 !M) one hour before the 
transfection and cell viability was detected using the MTT assay 14 hours after the 
treatment. Notably, inhibition of 12/15-LOX could not prevent tBid induced cell 
death (Figure 23a) suggesting that Bid activation occurs downstream of 12/15-LOX 
activity. Clearly, 12/15-LOX activity does not contribute to mitochondrial pathways 
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downstream of tBid toxicity. In addition, the vitamin E analog Trolox failed to prevent 
tBid induced toxicity (Figure 23b) confirming the note that Bid-mediated cell death 
did not require the formation of ROS but may involve other apoptotic pathways. 
As shown earlier in this study, increasing lipid peroxidation has been detected at 
different time points after glutamate treatment. Now, both, increased ROS formation 
and Bid activity have been identified as key mechanisms in glutamate-induced 
neurotoxicity, with Bid acting independent of 12/15-LOX.  
Thus it was next interesting to examine if Bid inhibition could also block the 
detected increases in ROS in a similar manner as 12/15-LOX inhibition.  
Lipid peroxidation was determined after the glutamate challenge in the presence or 
absence of the Bid inhibitor BI-6C9 using the BODIPY assay and subsequent FACS 
analysis. 
Interestingly, inhibition of Bid activation failed to reduce the increase of lipid 
peroxidation 6 - 8 h after glutamate challenge. In contrast, BI-6C9 significantly 
reduced the secondary increase in lipid peroxidation as determined 17 h after the 
glutamate treatment (Figure 23c, 23 d). Comparing these results with the data 
showing that 12/15-LOX inhibition also reduced the first increase in lipid 
peroxidation (6 – 8 h) these data confirmed the suggestion that the activation of 
12/15-LOX occurs upstream of Bid activation in HT-22 cells. The first increase in 
ROS seems is to be attributed to the activation of 12/15-LOX and is thus affected by 
12/15-LOX inhibitors but not by Bid inhibition.  
The secondary formation of ROS after 16 – 18 h is much stronger than the first 
increase and appears to be a consequence of mitochondrial damage and the 









Figure 23: 12/15-LOX activation triggers glutamate-induced oxytosis, upstream but 
not downstream of Bid. (a) PD146176 (0.5 µM) or AA861 (0.1 µM) were added to HT-22 
cells before the transfection with a tBid expression vector (ptBid). In addition, the cells were 
damaged with glutamate (2 mM) to control the sensitivity of the cells. Cell death was 
detected by using MTT assay 14 h after the transfection (n=8). (b) The vitamin E analog 
Trolox (50, 100 µM) was applied prior to the transfection of HT-22 cells with ptBid or 
exposure to glutamate (2 mM). MTT assay was used to determine cell viability 14 h later 
(n=8). (c + d) Lipid peroxidation was detected (c) 6 - 8 h and (d) up to 17 h after onset of 
glutamate exposure by FACS analysis after staining cells with BODIPY C11 (Ex = 488nm, 
Em = 530nm, 613nm). The Bid inhibitor BI-6C9 was present in the medium 1 h before and 
during the glutamate challenge (n=3). All experiments were repeated 3 times and the 
results are reported as mean ± S.D. *** P<0.001 compared with glutamate-treated cells 
(ANOVA, Scheffé test). 
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3.9. NADPH oxidase activation mediates mitochondrial demise 
in HT-22 neurons 
 
The previous results suggested a critical role of Bid-mediated mitochondrial demise 
and the subsequent pronounced increases in ROS during glutamate-induced 
oxidative stress in HT-22 cells. Previous studies suggested that NADPH oxidase 
activation can also mediate mitochondrial damage in neuronal cell death, in 
particular when triggered by ATP depletion and downstream of Bid-mediated 
mitochondrial damage [152-157].  
NADPH oxidase (NOX), is a cytosolic enzyme that catalyzes the transfer of an 
electron from NADPH to molecular oxygen and induces the formation of 
superoxide. Therefore, NOX may be a source of the enhanced ROS formation in 
the second phase of glutamate-induced oxytosis.  
In order to analyze the role of the NADPH oxidase in HT-22 neurons and especially 
its possible link to mitochondrial demise and the secondary increase in ROS the 
NOX inhibitor DPI (Diphenyleneiodonium chloride, Enzo Life Science, Lörrach, 
Germany) was applied. 
HT-22 cells were pretreated for one hour with DPI and exposed to glutamate (5 
mM) for 14 – 16 hours. Cell death was detected using different methods. In addition 
to MTT assays (Figure 24a) and detection of annexin V/propidium iodide (PI) 
staining (Figure 24b), impedance measurements (Figure 24c) were performed using 
the xCELLigence system (Roche Applied Science, Penzberg, Germany). The 
results showed that DPI (0.1 !M) protected the cells significantly against glutamate-
induced cell death suggesting that activation of the NADPH oxidase was involved in 





Figure 24: NOX inhibition prevents glutamate-induced cell death. The NOX inhibitor 
DPI (0.1 !M) was added 1 hour prior to the glutamate treatment (5 mM). Cell viability was 
evaluated with (a) the MTT assay, (b) annexin V/PI staining and (c) impedance 
measurements (c). The time point of the addition of glutamate is marked as “0 h” in the 
xCELLigence-graph. All experiments were repeated 3 times and the results are presented 




As DPI protected HT-22 cells against glutamate toxicity, it was interesting to 
examine the time-dependent role of NADPH oxidase in neuronal oxidative stress. 
Therefore, DPI was added at different time points between 2 h and 15 h after onset 
of the glutamate treatment. HT-22 cells were protected against glutamate toxicity 
even when DPI was added up to 8 h after the glutamate challenge indicating that 
beyond that time point glutamate-induced cell death proceeded too far for protection 




Figure 25: The NOX inhibitor DPI protects HT-22-cells when applied up to 8 h after 
glutamate treatment. DPI (0.1 !M) was added 2 – 15 h after glutamate challenge.  
Inhibition of the NADPH oxidase protected the cells even if DPI was added 8 h after 
glutamate-induced damage (n=8). Cell viability was detected by the MTT assay at 17 h 
after the onset of the treatment. The experiment was repeated 3 times and the results are 
presented as the mean ± S.D. *** P<0.001 compared with glutamate-treated cells (ANOVA, 
Scheffé-test). 
 
Since previous studies suggested a link of NADPH oxidase to mitochondrial demise 
the effect of NOX inhibition on mitochondria was further analyzed by monitoring the 
effect of DPI on mitochondrial morphology and ATP levels.  
For the investigation of mitochondrial morphology, the HT-22 cells were transfected 
with a plasmid inducing the expression of a green-fluorescent protein targeted to 
mitochondria (mitoGFP). The cells were analyzed using a fluorescence microscope 
(DMI 6000 B, Leica, Wetzlar, Germany; connected to a CCD camera DFC 360 FX, 
Leica, Wetzlar, Germany) for the quantification of mitochondrial morphology. For 
the quantification three different categories of mitochondrial morphology were 
defined (category 1: tubulin-like, category 2: intermediate, category 3: fragmented) 
and analyzed in at least 200 cells per condition.  
Interestingly, DPI reduced glutamate-induced mitochondrial fragmentation after 
glutamate challenge (Figure 26a) suggesting a link between mitochondrial demise 
and NOX activity in HT-22 cells. 
In order to explore the effect of glutamate-induced NOX activation on mitochondrial 
function ATP-levels were detected in the cells, because mitochondrial damage 
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results in loss of ATP production in the cells (ViaLight MDA Plus-Kit, Lonza, 
Verviers, Belgium). Concomitant with the cytoprotective effect, the NOX inhibitor 
DPI restored ATP levels in HT-22 cells and thus prevented the loss of energy 
associated with glutamate toxicity (Figure 26b). These results indicated a role for 
NADPH oxidase in glutamate-induced cell death in HT-22 cells and identified NOX 
as an important mediator of mitochondrial damage.  
!
Figure 26: NADPH oxidase inhibition preserves mitochondrial morphology and 
energy-metabolism. (a) HT-22 cells were transfected with mitoGFP and damaged with 
glutamate (3 mM) 24 h after the transfection. The NOX inhibitor DPI was added 1 h prior to 
glutamate. 16 h after the addition of glutamate mitochondrial morphology was evaluated 
(category 1: tubulin-like, category 2: intermediate, category 3: fragmented) (n=3). (b) ATP-
levels were determined by luminescens measurements after glutamate challenge. DPI 
prevented the glutamate-induced loss of ATP (n=8). All experiments were repeated 3 times 
and the results are presented as the mean ± S.D. ** P<0.01 compared with glutamate-
treated cells (ANOVA, Scheffé-test). 
!
For more detailed investigation on the role of NOX in glutamate-induced neuronal 
death the link between NOX and other important pro-apoptotic proteins was 
analyzed. In particular, the mechanistic link between Bid activation and NOX activity 
was investigated because of the key role for Bid activation in mitochondrial damage 
after induction of glutamate toxicity. 
The HT-22 cells were transfected with a tBid expression vector 24 h after the 
seeding and pretreated with DPI (0.1 and 10 µM) one hour before the transfection. 
Cell viability was evaluated using the MTT assay at 14 hours after the transfection. 
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It is interesting to note that DPI failed to prevent tBid-induced toxicity (Figure 27) 
indicating that NOX activation occurred upstream of Bid activation. 
 
!
Figure 27: DPI failed to prevent tBid induced cell death. HT-22 cells were pretreated 
with DPI (0.1 !M) and transfected with the pIRES tBid vector 24 h after the seeding. After 
12 h cell viability was evaluated with the MTT assay (n=4). The experiment was repeated 3 
times. The data are presented as mean ± S.D. 
 
 
In summary, these results showed a key role of NADPH oxidase in glutamate-










3.10. Inhibition of 12/15-LOX inhibits mitochondrial demise, the 
subsequent loss of ATP and preserves mitochondrial 
morphology 
 
The previous results suggested a link between 12/15-LOX and Bid activation and 
mitochondrial damage in HT-22 cells exposed to glutamate.  
Mitochondria play a key role in cell death induced by oxidative stress and 
mitochondrial fusion and fission processes are known to be involved in 
neurodegenerative processes and cell viability [31, 54, 55]. Functional breakdown 
of mitochondria leads to loss of ATP, increased ROS production and release of pro-
apoptotic proteins from the organelles. Consequently, the mitochondrial demise 
represents a crucial step in neuronal death. 
Here, pathological changes in mitochondria were assessed in further detail to 
elucidate the intrinsic pathways involved in glutamate toxicity in HT-22 cells.  
Loss of energy is known as key mediator of neuronal cell death because neurons 
depend on high levels of energy. For further determination of the mitochondrial 
12/15-LOX activity and the link to Bid activation, ATP levels were measured in HT-
22 cells after the glutamate challenge. 
Glutamate (5 mM) induced a strong loss of ATP in HT-22 cells suggesting 
glutamate-induced mitochondrial damage and permeabilization (Figure 28a). The 
first detectable loss of ATP became obvious between 6 and 12 hours after the 
exposure to glutamate indicating that the beginning of mitochondrial damage occurs 
in this time window. To test the effect of 12/15-LOX inhibition on the loss of ATP 
after glutamate treatment, PD146176 was added one hour before the glutamate 
challenge. The pretreatment with 12/15-LOX inhibitors completely prevented the 
loss of ATP in the cells after induction of oxidative stress (Figure 28b) showing that 





Figure 28: Glutamate induces loss of ATP that is prevented by PD146176. (a) ATP-
levels were detected at different time-points after glutamate challenge. Glutamate induced 
a time-dependent loss of ATP in HT-22 neurons. (b) PD146176 (0.5 !M) inhibits the loss of 
ATP after the exposure to glutamate. All experiments were repeated 3 times and the results 




These results suggested that 12/15-LOX activation leads to mitochondrial damage 
after exposure to glutamate in HT-22 neurons. In order to understand the effects on 
mitochondria, the next steps included analysis of the mitochondrial morphology and 
the mitochondrial membrane potential. 
For this purpose HT-22 cells were transfected with a vector inducing the expression 
of mitoGFP. The vector leads to the expression of a green fluorescent protein in 
mitochondria and allows the observation of mitochondrial morphology. Under 
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standard growth conditions, HT-22 cells contain elongated mitochondria whereas 
glutamate treatment induced pronounced mitochondrial fragmentation. 12/15-LOX 
inhibition reduced glutamate-induced fragmentation and increased the percentage 
of elongated mitochondria (Figure 29a, 29b) showing again that 12/15-LOX is a key 
mediator of mitochondrial damage and metabolism. 
!
Figure 29: The 12/15-LOX inhibitor PD146176 (0.5 µM) prevents glutamate-induced 
mitochondrial fragmentation. (a) HT-22 cells were transfected with mitoGFP using 
Lipofectamine 2000 and seeded in ibidi slides. Twenty-four hours later the cells were 
damaged with glutamate 5 mM (n=4). (b) Mitochondrial morphology was analyzed by 
fluorescence microscopy and classified into 3 categories indicating the status of fission and 
fusion (category 1: tubulin-like, category 2: intermediate, category 3: fragmented) (n=4). All 
experiments were repeated 3 times and the results represent the mean ± S.D. * P<0.05, *** 






In addition, the mitochondrial membrane potential was analyzed using the 
fluorescent dye JC-1 (2 !M). The loss of mitochondrial membrane potential is 
detected by a loss of red fluorescence that can be measured by FACS analysis. 
Carbonyl cyanide m- chlorophenylhydrazone (CCCP, 50 !M) that induces a fast 
and strong mitochondrial depolarization was used as positive control. The cells 
were examined 16 hours after glutamate challenge. Glutamate (2 mM) caused a 
loss of mitochondrial membrane potential as shown by the reduced number of cells 
with red fluorescence. PD146176 significantly reduced the glutamate-induced loss 
of mitochondrial membrane potential (Figure 30a, 30b). These data confirmed that 
12/15-LOX inhibition prevented mitochondrial damage thereby rescuing the HT-22 
neurons from glutamate toxicity. 
!
Figure 30: 12/15-LOX inhibition prevents the disruption of the mitochondrial 
membrane potential. (a, b) The mitochondrial membrane potential was measured using 
the JC-1 fluorescent dye. HT-22 cell were treated with glutamate (2 mM) and pretreated 
with PD146176 (0.5 !M). Sixteen hours later the cells were stained with JC-1 (2 !M) and 
analyzed by FACS measurements. CCCP (50 !M) was used as positive control to induce 
loss of the mitochondrial membrane potential. The green fluorescence (green Fl) indicates 
the loading of the cells with the dye whereas the red fluorescence (red Fl) is only detectable 
in cells with an intact mitochondrial membrane potential. Glutamate induced a loss of red 




In summary, 12/15-LOX influenced mitochondrial morphology, energy metabolism 
and also mitochondrial membrane potential thereby protecting the cells against 
glutamate toxicity. 
!
In order to further explore the potential role of 12/15-LOX on the mitochondrial level 
the cells were treated with rotenone (10 – 100 µM). Rotenone inhibits the 
mitochondrial electron transport chain at complex I and induces pronounced 
damage in HT-22 cells (Figure 31a, 31b). It was interesting to explore the effect of 
12/15-LOX inhibition on rotenone-induced damage to see whether 12/15-LOX may 
mediate cell death downstream of complex I inhibition. 
Cell viability was measured by the MTT assay at 16 hours after onset of the 
treatment with rotenone. It is interesting to note that PD146176, added one hour 
prior to rotenone, failed to protect the cells against complex I inhibition (Figure 31a).  
These data suggested that glutamate and 12/15-LOX do not mediate cell death by 
inhibition of the complex I of the mitochondrial respiratory chain. Interestingly, the 
vitamin E analog Trolox also failed to prevent rotenone induced cell death in HT-22 
cells (Figure 31b) showing that the formation of ROS may not play a major role in 
mediating cell death after complex I inhibition. In conclusion, the fact that neither 
antioxidants nor 12/15-LOX inhibitors could interact with rotenone toxicity 
suggested that complex I inhibition is of minor relevance in HT-22 cells after 
glutamate treatment and that neither LOX activity nor ROS formation alone 




Figure 31: Neither PD146176 nor Trolox protect HT-22 cells against rotenone toxicity. 
The complex I inhibitor rotenone (10 – 100 !M) induced cell death in HT-22 cells that could 
not be prevented by addition of (a) PD146176 (0.5 !M) or (b) Trolox (50 + 100 !M) (n=8). 
Cell viability was detected by the MTT assay at 16 hours after the exposure to rotenone. All 











3.11. Inhibition of 12/15-LOX prevents AIF translocation to the 
nucleus 
 
It has been shown that the translocation of the apoptosis-inducing factor (AIF) from 
the mitochondria to the nucleus is a crucial step in glutamate induced cell death in 
HT-22 cells and primary neurons [26, 158, 159]. The release of AIF from the 
mitochondria is triggered by different mediators, like e.g. Bid or Bax, and causes 
DNA degradation and cell death. In order to examine the link between 12/15-LOX 
activation in neuronal cell death and the execution of mitochondrial death pathways 
at low ATP levels the effect of PD146176 on glutamate-induced AIF translocation 
was addressed. 
The HT-22 cells were seeded in ibidi slides and treated with PD146176 (0.5 !M) 
and glutamate (5 mM). After 12 hours the cells were fixed with PFA (4%) and 
stained using a primary antibody against AIF (Santa Cruz Biotechnology, Inc, 
Heidelberg, Germany) and a biotinylated secondary antibody (Vector Labs, Axxora, 
Loerrach, Germany), which was linked to streptavidin oregon green (Invitrogen, 
Karlsruhe, Germany) for detection using a confocal fluorescent laser scanning 
microscope (Carl Zeiss AG, Jena, Germany). The nuclei were stained with DAPI to 
control the translocation to the nucleus. Glutamate induced detectable AIF 
translocation to the nucleus that was prevented by 12/15-LOX inhibition (Figure 
32a).  
For confirmation of the results obtained with immunostainings nuclear extracts of 
HT-22 cells were examined by western blot. The cells were damaged for 12 hours 
with glutamate and PD146176 was used again to inhibit 12/15-LOX activation. After 
12 hours nuclear and cytosolic extracts were prepared which were analyzed after 
western blotting using an anti-AIF antibody (Santa Cruz Biotechnology, Inc, 
Heidelberg, Germany). Translocation of AIF could be detected in the cells treated 
with glutamate whereas PD146176 significantly reduced the amount of AIF in the 
nucleus despite the exposure to glutamate (Figure 32b). 
Overall, these results show that the activation of 12/15-LOX mediates mitochondrial 
damage and the translocation of AIF to the nucleus showing again the key role of 




Figure 32: PD146176 prevents AIF translocation to the nucleus. (a) HT-22-cells were 
treated with glutamate (5 mM) 24 h after seeding. PD146176 (0.5 µM) was applied 1 h prior 
to glutamate. Cells were fixed and immunostained 12 h after the treatment. Nuclei were 
stained with DAPI. Pictures were taken with a confocal microscope (Carl Zeiss AG, Jena, 
Germany). The 12/15-LOX inhibitor prevented glutamate-induced translocation of AIF to the 
nucleus. (b) HT-22 cells were damaged with glutamate and treated with PD146176 as 
indicated. After 12 h nuclear extracts were obtained for western blot analysis of AIF. 







The aim of this study was to analyze the role of 12/15-lipoxygenases in glutamate-
induced neuronal cell death. The involvement of 12/15-LOX was characterized in 
immortalized mouse hippocampal HT-22 neurons and in primary neuronal cultures. 
In addition to glutamate toxicity that induced oxidative stress and increases in 
intracellular calcium levels in HT-22 cells and primary neurons, the role of 12/15-
LOX was also addressed in other models of oxidative stress including application of 
H2O2, Fe(II)-salts, 4-HNE and NO-donors. 
The results obtained here suggested a key role for 12/15-LOX in glutamate-induced 
neuronal cell death showing that inhibition of 12/15-LOX significantly reduced 
oxidative stress and protected HT-22 cells and primary neurons against glutamate 
toxicity. In addition, neuronal cultures obtained from Alox15-mice (12/15-LOX 
knock-out mice) showed less neuronal damage after the glutamate challenge 
compared to cells obtained from wild type mice. Furthermore, PD146176, a potent 
and selective inhibitor of 12/15-LOX, prevented the glutamate-induced loss of ATP, 
preserved the mitochondrial membrane potential and mitochondrial morphology and 
inhibited AIF translocation from the mitochondria to the nucleus. 
However, 12/15-LOX inhibition failed to prevent tBid-induced cell death in HT-22 
cells indicating that 12/15-LOX activation triggers pathways of mitochondrial death 
signaling upstream of Bid activation. Additionally, the study revealed that PD146176 
attenuated the deregulation of intracellular calcium and prevented cell death after 
OGD in primary neurons in vitro and significantly reduced infarct size after MCAO in 
vivo. 
In conclusion, these data suggest that the findings on a major role of 12/15-LOX as 
a key trigger of lethal oxidative stress induced by glutamate in HT-22 immortalized 
neurons were relevant for mechanisms of delayed neuronal death in models of 
cerebral ischemia. Therefore, 12/15-LOX and the associated downstream 
mediators of mitochondrial damage and cell death are promising targets for novel 




4.1. Glutamate in HT-22 cells: 12/15-LOX mediated cell death 
 
HT-22 cells do not express ionotropic glutamate receptors such as NMDA receptors 
or AMPA/Kainate receptors. Therefore, glutamate cannot induce rapid calcium 
influx and exitotoxicity in HT-22 cells but mediates cellular death by inhibition of 
cystine import and subsequent GSH depletion.  
In a recent study the functional loss of glutathione peroxidase 4 (GPx4) was 
identified as the underlying mechanism that links reduced glutathione levels to 
oxidative cell death [160]. In addition, it was unraveled that loss of GPx4 sparks 
12/15-LOX-derived lipid peroxidation and subsequent execution of caspase-
independent cell death by mitochondrial release of AIF in fibroblasts [160].  
In HT-22 cells glutamate blocks the glutamate-cystine antiporter (xc-transporter) 
and causes a lack of cysteine in the cell, which is required for glutathione (GSH) 
formation [28, 29]. GSH is an important antioxidative system that also regulates the 
activity of GPx4 and thus indirectly the activity of 12/15-LOX. According to recent 
findings in fibroblasts and primary neurons, reduced GSH levels cause reduced 
GPx4 activity and subsequent activation of 12/15-LOX. This may also apply in HT-
22 neurons, since also in these cells glutamate-induced GSH depletion was 
followed by an increase in lipid peroxidation, which is attributable to 12/15-LOX 
activation. 
The present study further revealed a secondary more pronounced burst of ROS 
levels, which was associated with mitochondrial damage (Figure 5). 
Pharmacological inhibitors of 12/15-LOX significantly protected HT-22 cells against 
glutamate-induced cell death, indicating a key role of 12/15-LOX activation as a 
primary trigger of cell death in the HT-22 cell model of glutamate toxicity (Figure 9, 
10).  
This is further supported by findings showing that glutamate triggered LOX-
dependent lipid peroxidation that occurred upstream of essential steps of 
glutamate-induced cell death in HT-22 cells. 
 
Since ROS can originate from different sources in the cell this study analyzed not 
only the role of 12/15-LOX but also the role of 5-LOX as well as of COX and 
NADPH oxidase (3.3 + 3.9). 
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This thesis showed that neither 5-LOX nor COX are involved in the formation of 
ROS in HT-22 cells because selective inhibitors of both enzymes failed to protect 
the cells against glutamate-induced cell death (Figure 8) whereas 12/15-LOX 
inhibition was highly protective. These findings further supported the key role 12/15-
LOX as trigger of glutamate-induced cell death in HT-22 cells. 
 
It is important to note that the calcium chelator EDTA significantly reduced cell 
death after glutamate challenge (Figure 7) indicating that disruption of calcium 
homeostasis plays a role in HT-22 cells. Supporting these findings Tan et al. 
reported elevated calcium levels after glutamate treatment in HT-22 cells [30]. 
However, EDTA failed to completely prevent glutamate-induced damage, in 
particular at high concentrations of glutamate, suggesting that Ca2+ influx 
contributed to cell death but was dispensable and less important than pronounced 
lipid peroxidation.  
In summary, these data connect the HT-22 cell model to glutamate-induced 
excitotoxicity in primary neurons as they highlight two trigger mechanisms of cell 
death, i.e. increased production of ROS and elevated levels of intracellular calcium 
that these two models have in common.  
It has been shown that the activation of the pro-apoptotic Bcl-2 protein Bid is 
required for induction of damage and depolarization of mitochondria in HT-22 cells 
[26, 150]. Others have shown that after activation and translocation to mitochondria 
Bid interacts with the Bcl-2 family member Bax and induces the formation of a 
mitochondrial pore and the subsequent breakdown of the mitochondrial membrane 
potential indicating the important role of the Bid protein in neuronal demise [31, 34].  
In addition, it is known that Bid activation and the subsequent mitochondrial 
damage induce translocation of AIF (apoptosis inducing factor) from the 
mitochondria to the nucleus. The translocation of AIF is known to be a crucial step 
in caspase-independent apoptosis in HT-22 cells [26]. 
Taken together, these data suggested that Bid activation and the subsequent AIF 
translocation are key mediators of neuronal cell death in HT-22 cells. In addition, 
this thesis now showed that 12/15-LOX activation is important in oxidative stress-
induced cell death in HT-22 cells and that 12/15-LOX dependent mechanisms of 




4.2. 12/15-LOX-dependent Bid activation  
 
Since 12/15-LOX inhibition was highly protective in glutamate-induced neuronal cell 
death the pro-apoptotic pathways, which are connected to 12/15-LOX activation, 
were analyzed in further detail with special interest in the connection between 
12/15-LOX activation and the important pro-apoptotic proteins Bid and AIF. The 
importance of Bid activation and AIF translocation in HT-22 cells as major steps in 
neuronal damage was confirmed in this thesis which now links GSH depletion, 
12/15-LOX activation and these key events of intrinsic death signaling [26, 150].  
Bid has been revealed as key mediator of cell death in different paradigms of 
neurodegeneration, including model systems of oxidative stress and excitotoxicity in 
vitro, and cerebral ischemia and brain trauma in vivo [38, 40, 161].  
Accordingly, Bid knockout mice developed significantly reduced brain damage after 
cerebral ischemia and brain trauma [37]. Similar results were obtained in cultured 
neurons from Bid-deficient mice when exposed to oxygen glucose deprivation 
(OGD) [38]. Further, small molecule inhibitors of Bid provided protective effects 
against glutamate-induced excitotoxicity or OGD in cultured primary neurons [150]. 
The selective Bid inhibitor BI-6C9![151] also prevented mitochondrial demise [150], 
AIF release and cell death in HT-22 cells exposed to oxidative stress induced by 
glutamate or amyloid-beta peptide [26, 131]. All of these different paradigms of 
lethal stress induced activation of Bid, which translocated to the mitochondria where 
it mediated mitochondrial membrane permeabilization and release of death inducing 
proteins such as cytochrome c or AIF. Therefore, Bid activation is a common 
feature of death signaling that can significantly amplify deadly stress signals 
through involvement of mitochondrial mechanisms in the execution of cell death.   
Both, 12/15-LOX- and Bid-inhibition, were able to protect the HT-22 cells up to 
control level against glutamate toxicity (Figure 9, 22) strengthening the importance 
of the two proteins and their possible link in the cascade of cell death signaling.  
Measurement of lipidperoxides using the fluorescent dye BODIPY showed that 
inhibition of 12/15-LOX could prevent the first increase in lipidperoxides as well as 
the secondary burst after mitochondrial damage (Figure 10). In contrast, the 
selective Bid inhibitor BI-6C9 reduced only the secondary burst of ROS (16 – 18h) 
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and did not influence the first ROS formation (6 – 8h) suggesting that Bid activation 
occurs downstream of 12/15-LOX activity (Figure 23).  
Indeed, the proposed timing of transition from moderate to severe oxidative stress 
fits well with the timing of Bid translocation to mitochondria and indicators of 
mitochondrial damage such as loss of mitochondrial membrane potential and 
subsequent release of AIF as determined in previous work [26].  
Of note, 12/15-LOX inhibition as well as antioxidants and NADPH oxidase inhibitors 
failed to prevent tBid-induced damage (Figure 23, Figure 27) whereas the Bid 
inhibitor BI-6C9 prevented tBid toxicity [26]. These results confirmed the proposed 
time course of 12/15-LOX activation and subsequent Bid activity. Further, these 
data clearly suggest that 12/15-LOX activity and further ROS formation is not 
essential for the further damage of mitochondria and execution of cell death 
downstream of Bid. Thus, the observed secondary burst of ROS indicates the ‘point 
of no return’, i.e. fatal damage to the mitochondria that cannot be reversed by 
antioxidants or inhibitors of 12/15-LOX. 
It is important to note that previous studies showed similar effects on mitochondria 
and AIF-dependent cell death in HT-22 cells for both, mitochondrial translocation of 
full length Bid after the glutamate challenge and over-expression of tBid [26]. 
Consequently, the transfection with a tBid-expressing vector is a potential model for 
Bid-induced toxicity and was therefore used in this study.  
Previous studies showed that Bid cleavage could not be detected after exposure to 
glutamate in HT-22 cells as well as in primary neurons, suggesting that full length 
Bid translocated to the mitochondria and/or only a small part of Bid was cleaved to 
tBid [26, 52]. This is in line with reports that suggested activation and mitochondrial 
translocation of full length Bid prior to Bid cleavage and execution of mitochondrial 
death pathways [162]. It is important to note that the Bid inhibitor BI-6C9 prevented 
the translocation of full length Bid and tBid to mitochondria and the according 
detrimental effects on mitochondria, suggesting that the effects of both forms of 
activated Bid on mitochondria are comparable.  
The exact mechanisms of Bid activation in the present model system are currently 
unknown and matter of ongoing studies. 
In summary, these data strongly suggest that activation of 12/15-LOX and formation 
of ROS initiated cell death mechanisms after glutamate treatment, whereas 
activation of Bid, mitochondrial damage and the boost of ROS are hallmarks of 
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downstream mechanisms that cannot be blocked by 12/15-LOX inhibitors or radical 
scavengers. These findings also contrast recent reports from studies in isolated 
mitochondria suggesting a function of activated 12/15-LOX at the mitochondrial 
membrane [149]. The present findings clearly indicate that in whole cells, 12/15-
LOX may function as a trigger for other mediators of mitochondrial damage 
whereas 12/15-LOX may play only a minor role once these mediators induced 
damage at the mitochondria.  
These assumptions are supported by experiments showing that cell death induced 
by the complex I inhibitor rotenone was neither prevented by 12/15-LOX inhibition 
nor by the antioxidant Trolox in HT-22 neurons (Figure 31). 
 
In particular, the present findings suggest a transition phase where Bid acts as a 
crucial link between the 12/15-LOX-dependent initial increases in lipid peroxidation 
and the following mitochondrial damage. This conclusion is supported by previous 
studies where the small molecule Bid inhibitor BI-6C9 or Bid siRNA prevented 
mitochondrial damage, AIF translocation and cell death in neurons [26]. Moreover, 
the therapeutic time window of 8-10 h identified in previous studies for the Bid 
inhibitor [26] is in accordance with the ‘point of no return’ and the associated 
secondary boost of oxidative stress revealed in the present study. Here, the LOX 
inhibitor PD146176 and the antioxidant Trolox showed a similar therapeutic time 
window of approximately 8 h after onset of the glutamate challenge (Figure 11). 
This supports the view that accumulating oxidative stress leads to Bid-mediated 
mitochondrial damage, which marks the execution phase of cell death that cannot 
be blocked, by LOX inhibitors or radical scavengers targeting the initiation phase.  
In summary, the present study shows an important role for Bid acting as a key link 
between early ROS formation by 12/15-LOX and downstream mitochondrial 
damage that executes cell death after glutamate challenge in neuronal cells. 
 
 
4.3. 12/15-LOX activation mediates AIF-translocation 
 
The translocation of AIF from mitochondria to the nucleus is a key feature of 
caspase-independent neuronal death as shown previously in models of glutamate 
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toxicity, oxygen glucose deprivation and axonal stretch injury [26, 163]. In addition, 
previous studies showed that AIF-mediated cell death is dominant in HT-22 cells 
while activation of caspases occurs only at very late time-points after glutamate 
challenge [26]. Further, inhibition of caspase activity did not prevent glutamate-
induced death in HT-22 cells indicating a minor role of these proteases in the 
current model system of oxytosis [26]. 
 
It has been demonstrated that AIF knockdown with siRNA is protective in HT-22 
cells after glutamate challenge [26]. In addition, Hq mice, which express only about 
20% AIF, in comparison to wild type mice, exhibit protection against different pro-
apoptotic stimuli like MCAO or glutamate-induced excitotoxicity [164][158]. There is 
not much known about the process of mitochondrial AIF release and nuclear 
translocation but others proposed that AIF, which is localized at the inner 
membrane of the mitochondrial intermembrane space, has to be cleaved before its 
translocation [165, 166]. Possible candidates for the proteolytic cleavage of AIF are 
for example calpains [46]. Calpains belong to the family of calcium-dependent, non-
lysosomal cysteine proteases that mediate processes such as cell cycle 
progression, cell mobility and cell-type specific functions like long-term potentiation 
in neurons.  
Additionally, inhibition of poly (ADP-ribose) polymerase 1 (PARP-1) attenuated 
damage of HT-22 cells after glutamate challenge (Landshamer, “Role of Bid and 
AIF in glutamate-induced neuronal cell death“, dissertation 2007). Others have 
shown before that PARP-1 inhibition was also protective in OGD or MCAO in mice 
[158]. Furthermore, PARP-1 can cause depletion of NAD+ suggesting that 
mitochondrial NAD+ depletion connect PARP-1 activation to the release of AIF 
[167].  
In addition, mitochondrial translocation of the BH3-only death agonists Bid, Bim or 
BNIP3 have been associated with AIF translocation in neurons supporting the 
important role of AIF and the activation of pro-apoptotic Bcl-2 proteins in neuronal 
demise [26, 158, 168, 169]. 
These data show the important role of AIF-induced caspase-independent cell death 
in HT-22 cells as well as in primary neurons therefore the role of AIF was explored 
in further detail in this study.  
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In this thesis HT-22 cells were stained for AIF using an anti-AIF antibody (Santa 
Cruz Biotechnology, Inc., Heidelberg, Germany) to explore if 12/15-LOX inhibition 
can prevent translocation of AIF to the nucleus and to investigate the potential link 
between 12/15-LOX activation and AIF translocation.  In order to confirm the results 
nuclear and cytosolic extracts of HT-22 cells were analyzed by western blotting. 
Both experiments showed that the 12/15-LOX inhibitor PD146176 prevented AIF 
translocation to the nucleus after glutamate-induced damage (Figure 32a, 32b). 
Overall, these data suggest that 12/15-LOX activation mediate subsequent AIF 
translocation. This demonstrates again the important role of 12/15-LOX activation in 
neuronal damage.  
Regarding the results obtained from analysis of tBid toxicity in HT-22 cells (see 4.2) 
these results suggest a potential link between 12/15-LOX, Bid activation and the 
translocation of AIF from the mitochondria to the nucleus. 
 
 
4.4. 12/15-LOX activation and mitochondrial demise 
 
This thesis revealed a link between 12/15-LOX and the activation of Bid and AIF, 
which indirectly suggests a strong effect of 12/15-LOX on mitochondrial death 
pathways. A role for 12/15-LOX as an upstream trigger of mitochondrial execution 
mechanisms of cell death was further supported by analysis of mitochondrial 
morphology, mitochondrial membrane potential and loss of ATP after glutamate 
challenge (Figure 28, 29, 30). Mitochondria are crucial organelles of every cell as 
they are the primary source of energy and perform decisive tasks in the process of 
cell differentiation and are involved in the synthesis of neurotransmitters and the 
maintenance of ion homeostasis. 
Mitochondria are dynamic organelles that undergo permanent fission and fusion 
under physiological conditions. In damaged neurons however, this dynamic process 
is disturbed leading to excessive fragmentation of mitochondria and thereby 
promoting cell death progression [61, 123, 170]. Although the mechanisms 
controlling mitochondrial morphology under pathological conditions are only partly 
known, increasing evidence suggests a potential role for oxidative stress and 
impaired bioenergetics as potential triggers of mitochondrial fission in the cell death 
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program [150]. The present study demonstrates that glutamate-induced cell death is 
associated with mitochondrial fragmentation in HT-22 cells (Figure 29). Inhibition of 
12/15-LOX prevented glutamate-induced disruption of the mitochondrial 
morphology, blocked loss of ATP after glutamate challenge and preserved the 
mitochondrial membrane potential (Figure 28, 29, 30). These data suggest that 
activation of 12/15-LOX is an important upstream stimulus of glutamate-induced 
neurotoxicity resulting in enhanced mitochondrial fission, loss of mitochondrial 
integrity, loss of energy (ATP) and progression of AIF-dependent cell death.  
 
 
4.5. 12/15-LOX in primary neurons 
 
Further studies have shown a key role of 12/15-LOX in different models of neuronal 
cell death [133, 134]. Recent work in models of cerebral ischemia exposed LOX as 
a potential target for neuroprotective strategies in stroke treatment. In these studies, 
genetic 12/15-LOX deletion significantly reduced the infarct size in a mouse model 
of transient cerebral ischemia as compared to wild type mice, and similar protective 
effects against ischemic brain damage were achieved by treating wild type mice 
with the LOX inhibitor baicalein [133]. It is important to note that baicalein is 
supposed to inhibit 12/15-LOX but it has been shown that it also has antioxidant 
properties, which may partly contribute to the protective effects achieved in vitro 
and in vivo where baicalein was applied in very high doses. Consequently, in the 
present study the selective 12/15-LOX inhibitor PD146176 was chosen for the 
experiments.  
The present thesis demonstrated a protective effect of 12/15-LOX inhibition in 
glutamate-induced excitotoxicity as well as in oxygen glucose deprivation. In 
addition, this study showed that glutamate-induced toxicity was significantly 
reduced in neuronal cultures obtained from 12/15-LOX-knockout mice compared to 
wild type cultures confirming the key role of 12/15-LOX activity in oxidative stress 
induced neuronal cell death. Further, PD146176 also significantly reduced the 
infarct volume after MCAO and improved the neuroscore of the treated mice 
showing that 12/15-LOX inhibition reduced ischemic brain damage and improved 




Disruption of calcium homeostasis occurs after glutamate-induced excitotoxicity in 
primary neurons. Excitotoxicity is supposed as a pathological mechanism of 
neuronal death in different neurodegenerative diseases like Alzheimer’s Disease, 
Parkinson’s Disease and also contributes to infarct development after acute brain 
damage by trauma or ischemia [171, 172]. Glutamate induced a fast calcium 
increase and a secondary delayed calcium deregulation in primary cortical neurons 
that was influenced by 12/15-LOX inhibition. The 12/15-LOX inhibitor PD146176 did 
not prevent the initial short increase in [Ca2+]i after glutamate exposure but 
significantly attenuated the secondary sustained increase in intracellular calcium 
levels and concurrently reduced cellular death. These findings support the 
conclusion that the 12/15-LOX inhibitors interfered with delayed downstream 
execution mechanisms of glutamate neurotoxicity, such as ROS formation, 
sustained increases in [Ca2+]i and mitochondrial damage. Others have postulated 
before a direct interaction of 12/15-LOX with calcium channels that would explain 
the effect of 12/15-LOX activation on calcium homeostasis [173].  
 
Thus, lipoxygenases are promising targets for therapeutic strategies against 
glutamate-mediated death signaling that may occur in the presence or absence of 
glutamate receptor ion channels. 
 
 
4.6. The role of NADPH oxidase (NOX) in HT-22 neurons 
 
Activation of the neuronal glutamate receptors initiates several downstream events, 
including cation influx, activation of nitric oxide synthase and formation of 
superoxide [174-176]. Superoxide functions as an inter-cellular messenger in long-
term potentiation [177, 178] and participates in redox inhibition of glutamate 
receptor function [179]. However, superoxide can also promote neuronal death 
when glutamate receptor activation is sustained [174, 180]. A possible source of 
superoxide and lipidperoxides, is NADPH oxidase (NOX). NOX is a cytoplasmic 
enzyme that transfers an electron from NADPH to molecular oxygen to generate 
superoxide. NOX was originally described in neutrophils, but has subsequently 
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been identified in many other cell types including neurons [153, 181]. Neurons 
express the NOX2 isoform of NADPH oxidase and may also express the NOX1 and 
NOX4 isoforms [153]. 
Others have shown that inhibition of NOX prevents NMDA toxicity in neurons and 
suggested NOX as the major source for superoxides in neurons [154]. 
This study evaluated the role of NOX in HT-22 cells and the involvement of NOX in 
the induction of ROS formation and the induction of mitochondrial demise. 
The NOX inhibitor diphenyleneiodonium chloride (DPI) protected HT-22 cells 
against glutamate-induced cell death even when it was applied up to 8 hours after 
the exposure to glutamate (Figure 24, 25). In addition, DPI preserved the 
mitochondrial morphology (Figure 26a), suggesting that NOX also contributed to 
glutamate-induced mitochondrial damage. NOX inhibition also prevented the loss of 
ATP after glutamate challenge (Figure 26b) confirming the effect of NOX on 
mitochondria. This finding supplemented recent reports indicating that NOX 
activation links NMDA-receptor mediated increases in [Ca]i levels and ROS 
formation [154].  
This thesis suggests that NOX activity is also involved in glutamate-induced ROS 
formation and cell death in the absence of NMDA-receptors. Loss of ATP, 
arachidonic acid formation or elevated intracellular calcium levels, among others 
[182], can also activate NOX.  
Therefore, the observed slight changes in calcium concentration, loss of ATP or 
formation of arachidonic acid may induce NOX activation in HT-22 cells exposed to 
glutamate. It is, however, important to note that the exact mechanisms of NOX 
activation and of NOX-mediated cellular damage in HT-22 cells are not known, yet. 
Others have suggested an activation of PARP-1 after the exposure to glutamate, 
which leads to a decrease of NAD+, and therefore might induce Bid-mediated AIF 
translocation [157]. NOX is expressed in the cytosol and its activation can also 
induce PARP-1 mediated NAD+ depletion [156] suggesting that therefore the 
cytosolic protein Bid becomes activated and can mediate subsequent AIF 
translocation. This hypothesis explains the protective effect of the NADPH oxidase 
inhibitor DPI in HT-22 cells as well as the fact that DPI did not prevent tBid-induced 





4.7. NO in HT-22 cells 
 
Several studies have implicated nitric oxide (NO) as a key mediator of 
neurodegeneration in numerous neurodegenerative diseases including Parkinson’s 
Disease, Alzheimer’s Disease, Huntington’s Disease, and ischemic brain injury 
[102-105, 183, 184]. On the other hand, NO mediates different physiological 
functions like dilation of blood vessels and elimination of pathogens. NO toxicity 
primarily occurs after its conversion into highly reactive and toxic molecules that 
react with proteins, DNA, and lipids to alter their function and thereby induce cellular 
death [101]. 
In the present study, the role of NO production in HT-22 cells was analyzed in 
further detail. NO-toxicity was induced by the NO-donor DEANONOate (2 – 5 mM) 
and by sodium nitroprusside (SNP), which induces NO-release as well as the 
formation of CN- and Fe2+. Inhibition of 12/15-LOX failed to protect HT-22 cells 
against toxicity induced by DEANONOate (Figure 19b) as well as cell death induced 
by SNP (Figure 20b) demonstrating that both substances cause neuronal cell death 
independently of 12/15-LOX activity. DEANONOate leads to a fast but short-term 
increase in NO-concentrations while SNP induces a continuous, endogenous 
production of NO, CN- and Fe2+. Consequently, these results suggest different 
mechanisms of cell death for a fast and short lasting increase of NO, compared to a 
continuous NO production associated with additional stress stimuli. In fact, the cell 
death induced by SNP appears to be more complex than the damage induced by 
direct addition of NO-donors like DEANONOate and it is not possible to indentify the 
final trigger of cell death after SNP treatment in HT-22 cells. Previous studies 
showed that the CN-, that functions as mitochondrial toxin and induces oxidative 
stress, is released prior to the formation of NO and Fe2+ and therefore CN- may be 
the most important stress stimulus after exposure to SNP. However, it is also 
important to note that SNP induced glutathione depletion and upregulation of NF&B 
in neuronal cells [185] suggesting GSH depletion as an additional mechanism for 
SNP toxicity in HT-22 cells. Nevertheless, GSH depletion seems to be not the most 
important trigger of SNP toxicity because 12/15-LOX inhibitors failed to prevent 
SNP toxicity and because it has been elucidated before that decreased GSH levels 
mediate 12/15-LOX activation. 
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Interestingly, preliminary data showed that SNP does not induce nitrosylation of 
tyrosine residues in HT-22 cells suggesting that NO is not the major trigger of SNP-
induced cellular damage (Figure 20c). 
Furthermore, this study analyzed whether NO is released after glutamate challenge 
in HT-22 cells and analyzed the role of NO production and protein nitrosylation after 
glutamate treatment in the HT-22 model system. For this purpose, total cellular 
protein extracts were analyzed with western blotting and tyrosine-nitrosylation was 
detected using an anti-nitro tyrosine antibody (New England Biolabs GmbH, 
Heidelberg, Germany). Interestingly, there was no nitrosylation of tyrosine residues 
detectable after the exposure to glutamate showing that NO-toxicity is less 
important in glutamate-induced oxidative stress in HT-22 cells (Figure 21).  
 
 
4.8. The role of 12/15-LOX in other models of oxidative stress 
 
In this study several well-accepted models of oxidative stress that had been 
previously used in other studies of neurodegenerative diseases were tested in HT-
22 cells to analyze the role of 12/15-LOX [139, 140, 186]. Radical donors like 
glucose oxidase (GO) and H2O2, iron sulfate and HNE, which induces lipidperoxide 
formation, were used to investigate whether activation of 12/15-LOX occurs also in 
these model systems of oxidative stress. Inhibition of 12/15-LOX failed to prevent 
cell death induced by the radical donors glucose oxidase and H2O2. These results 
showed that cell death occurring after the exposure to radical donors differs from 
glutamate-induced apoptotic cascades and is not mediated by 12/15-LOX 
activation. On the other hand, the antioxidant NAC was able to prevent cell death 
induced by radical donors and glutamate (Figure 6b, 16c).  
Taken together, these results confirmed the key role of ROS production after 
glutamate challenge and demonstrated that the mechanisms, occurring in HT-22 
cells after glutamate challenge, differ from those after treatment with radical donors.  
In addition, it is important to note that the direct addition of H2O2 does not reflect 
physiological H2O2 formation. The treatment with GO may better mimic continuous 
release of H2O2 but both model systems are currently under debate concerning their 
suitability for research on mechanisms of neurodegeneration. 
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Moreover, HNE was used to induce cellular damage in HT-22 cells. HNE is known 
to be both, a marker and mediator of oxidative stress, and a possible contributor to 
Alzheimer’s Disease and atherosclerosis, an inhibitor of growth modulating factor 
and a signaling molecule in the induction of apoptosis [187-189].  
Peroxidation of cellular membrane lipids, or circulating lipoprotein molecules 
generate highly reactive aldehydes among which one of the most important is HNE. 
HNE was used in several studies on neurodegenerative diseases for induction of 
neuronal demise. This thesis analyzed the effect of HNE in HT-22 cells and 
examined the role of 12/15-LOX after the exposure to HNE. 12/15-LOX inhibition 
failed to prevent HNE-induced damage demonstrating that HNE-mediated cellular 
damage is independent of 12/15-LOX-activation (Figure 18).  
Furthermore, iron sulfate was used to induce Fe2+-toxicity and subsequent ROS 
production in HT-22 cells. It is known that Fe2+-levels in the brain are increased in 
several neurodegenerative diseases and that Fe2+-formation contributes to neuronal 
oxidative stress [142]. Therefore, induction of neuronal death with iron sulfate has 
been used in different studies on neurodegeneration, before. Interestingly, iron 
sulfate-induced cell death was not attenuated by 12/15-LOX inhibition and not by 
the antioxidant NAC (Figure 17b, 17c) showing that Fe2+-induced toxicity does not 
depend on 12/15-LOX activation and is not only mediated by ROS formation but 
may also induce other pro-apoptotic mechanisms.  
 
In summary, the results obtained for all different models of oxidative stress 
demonstrate that glutamate induces a very specialized form of oxidative stress that 
is not comparable to cell death induced by radical donors, HNE or NO.  
The activation of 12/15-LOX is apparently linked specifically to glutamate-induced 
oxidative stress and does not occur in the other tested models of oxidative stress. 
It is important to note, however, that the addition of glutamate reflects pathological 
conditions much better than the other models showing again the suitability of HT-22 








Overall, this thesis identified 12/15-LOX as a key trigger in glutamate neurotoxicity, 
in particular for glutamate-induced oxidative stress that is initiated by glutathione 
depletion, significantly amplified by Bid-dependent mitochondrial damage, and 
executed through mitochondrial AIF release to the nucleus. The delineated 
sequences of glutamate-induced cell death signaling in HT-22 cells (Figure 33) are 
highly relevant for neurodegenerative diseases and acute neurological disorders 
such as ischemic stroke, since glutamate toxicity and downstream mitochondrial 
death pathways have been identified as key features of neuronal death in related 
experimental models in vitro and in vivo. Thus, targeting 12/15-LOX is proposed as 
a potential therapeutic target for neuroprotective strategies in neurological diseases 
where glutamate-induced neuronal death is prominent. 
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Figure 33: Proposed mechanism of glutamate-induced oxidative stress in HT-22 
cells. Glutamate inhibits the Xc- transporter and thereby triggers glutathione depletion. 
Consequently, the activity of glutathione peroxidase-4 (GPx4) is reduced, while 12/15-LOX 
activity increases. 12/15-LOX activation induces a first increase in ROS and the 
translocation of Bid to the mitochondria where activated Bid induces mitochondrial 
fragmentation and mitochondrial membrane permeabilization. This results in reduced ATP 
production, pronounced increases in ROS production and, finally, release of pro-apoptotic 
proteins like AIF from the mitochondria. Upon mitochondrial release, AIF immediately 
translocates to the nucleus where it causes DNA damage and cell death independent of 





Oxidative stress has been established as a key trigger of neuronal dysfunction and 
death in age-related neurodegenerative diseases and in delayed neuronal death 
after acute brain injury by ischemic stroke or brain trauma. Despite increasing 
knowledge on the toxicity of reactive oxygen species (ROS) and oxidized reaction 
products that may further accelerate neuronal cell death, the major sources of ROS 
formation and the mechanisms involved in cell death signaling triggered by 
oxidative stress in neurons are poorly defined. Therefore, major aims of this study 
included the characterization of key enzymes that contribute to the formation of 
ROS and key factors of the downstream signaling pathways that may amplify the 
oxidative cellular stress thereby causing irreversible damage and death in neurons. 
Major parts of the study were performed in a model of glutamate toxicity in 
immortalized hippocampal HT-22 neurons, since glutamate selectively induced 
oxidative stress through glutathione depletion in these cells. To verify the relevance 
of the findings in HT-22 cells for post-mitotic neurons, further experiments included 
models of glutamate-induced excitotoxicity and oxygen-glucose deprivation primary 
embryonic neurons in vitro and in a mouse model of cerebral ischemia in vivo. 
 
The findings of these studies revealed that 12/15-lipoxygenases (LOX), but neither 
5-LOX nor COX activation, mediated glutamate-induced lipid peroxidation and 
oxidative cellular death (oxytosis) in HT-22 cells. Pharmacological inhibition of 
12/15-LOX protected HT-22 cells as well as primary neurons against glutamate 
toxicity. This protective effect included significantly reduced ROS formation and 
attenuated deregulation of the intracellular calcium homeostasis in the cultured 
neurons. Moreover, the 12/15 LOX inhibitor PD146176 reduced neuronal cell death 
after OGD in primary neurons in vitro, and significantly reduced the infarct volume 
after MCAO in vivo.  
Further experiments addressing the involved signaling pathways linked, for the first 
time, 12/15-LOX activation and key mediators of mitochondrial death pathways. In 
particular, the selective 12/15-LOX inhibitor PD146176 reduced mitochondrial 
fragmentation and ATP depletion after exposure to glutamate in HT-22 cells. Most 
interestingly, this study identified the pro-apoptotic Bcl-2 protein Bid as a key link 
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between 12/15-LOX activation, mitochondrial demise and the translocation of the 
mitochondrial protein AIF to the nucleus. In fact, mitochondrial transactivation of Bid 
downstream of 12/15-LOX activation was exposed as the key step for the 
mitochondrial damage that resulted in a second burst of lipid peroxidation and 
marked the ‘point of no return’ in the glutamate-induced death cascade.  
In summary, the glutamate-induced cell death mechanisms in HT-22 cells are highly 
relevant for neurodegenerative diseases and acute neurological disorders.  
Thus, 12/15-LOX is proposed as a potential therapeutic target for neuroprotective 




























Oxidativer Stress spielt bei der Entstehung neurodegenerativer Erkrankungen und 
neuronalem Zelltod nach traumatischen und ischämischen Hirnschädigungen eine 
wichtige Rolle. Trotz vermehrter Forschung auf dem Gebiet des oxidativen Stresses 
ist bis heute nicht bekannt, welche Zelltodmechanismen durch reaktive 
Sauerstoffspezies (ROS) ausgelöst werden und wie deren Bildung verursacht wird. 
Folglich sollten in dieser Arbeit Mechanismen genauer untersucht werden, die beim 
neuronalen Zelltod zur Entstehung von ROS beitragen. Des Weiteren sollten auch 
die Signalkaskaden näher charakterisiert werden, die durch oxidativen Stress 
letztlich zum neuronalen Zelltod führen. 
Im Rahmen dieser Arbeit wurde vor allem eine neuronale hippokampale Zelllinie 
(HT-22 Zellen) verwendet, die dadurch gekennzeichnet ist, dass eine Schädigung 
mit Glutamate zu einem kontinuierlichen Abfall der intrazellulären Glutathionspiegel 
führt und somit oxidativen Stress induziert. Zusätzlich wurden primäre neuronale 
Zellkulturen und ein in vivo-Modell der zerebralen Ischämie eingesetzt, um die in 
HT-22 Zellen erhaltenen Ergebnisse zu bestätigen und auszubauen. 
Die Ergebnisse dieser Untersuchung zeigen, dass nach Glutamatschädigung vor 
allem 12/15-Lipoxygenasen für die Bildung reaktiver Sauerstoffspezies in den 
neuronalen Zellen verantwortlich sind und somit im Rahmen des 
glutamatinduzierten oxidativen Stresses eine entscheidende Rolle spielen. 
Es konnte dagegen ausgeschlossen werden, dass Cyclooxigenasen (COX) und 5-
LOX zur Bildung von ROS nach Glutamatschädigung von HT-22 Zellen beitragen. 
Durch Hemmung bzw. genetische Deletion der 12/15-LOX konnte sowohl in HT-22 
Zellen als auch in primären neuronalen Kulturen eine deutliche protektive Wirkung 
gegenüber Glutamatschädigung gezeigt werden. Zusätzlich konnten, die nach 
Glutamatbehandlung auftretenden erhöhten Konzentrationen von reaktiven 
Sauerstoffspezies durch 12/15-LOX-Inhibition deutlich reduziert werden und auch 
die glutamatinduzierte Störung der Calciumhomöostase wurde durch den selektiven 
12/15-LOX-Inhibitor PD146176 deutlich verringert. PD146176 reduzierte zudem 
den neuronalen Zelltod nach Sauerstoff-Glucose-Entzug in primären Neuronen und 




Weitere Untersuchungen beleuchteten den Zusammenhang zwischen der 
Aktivierung von 12/15-LOX und mitochondrialer Schädigung, die wiederum durch 
einen starken Anstieg der reaktiven Sauerstoffspezies gekennzeichnet war. Durch 
Hemmung der 12/15-LOX wurde sowohl der glutamatinduzierte Abfall der ATP-
Spiegel als auch die Fragmentierung der Mitochondrien verhindert. Zusätzlich 
wurde im Rahmen dieser Studie zum ersten Mal gezeigt, dass die Schädigung von 
Mitochondrien nach der initialen Aktivierung der 12/15-LOX und Bildung größerer 
Mengen ROS vor allem durch das proapoptotische Bcl-2 Protein Bid vermittelt wird. 
Nach diesen Befunden induziert 12/15-LOX-Hemmung über die Aktivierung von Bid 
die Depolarisation der Mitochondrienmembran und die Translokation des 
mitochondrialen proapoptotischen Proteins AIF in den Zellkern, wo AIF über die 
Zerstörung der DNA die Endphase des Zelltods einleitet. 
 
Zusammenfassend konnte in dieser Arbeit dargestellt werden, dass 12/15-LOX 
über die Bildung von ROS eine wichtige Stellung im glutamatinduzierten oxidativen 
Stress einnimmt. Nach dem Abfall von Glutathion in der Zelle werden 12/15-
Lipoxygenasen aktiviert und bewirken in der Folge eine Aktivierung des 
cytotoxischen Proteins Bid, dass die Schädigung von Mitochondrien vermittelt. 
Durch die mitochondriale Schädigung kommt es zum Abfall von ATP-Spiegeln 
sowie zur Bildung weiterer großer Mengen reaktiver Sauerstoffspezies und zur 
Freisetzung proapoptotischer Proteine wie AIF aus den Mitochondrien. 
Im Rahmen dieser Arbeit konnte daher gezeigt werden, dass 12/15-Lipoxygenasen 
möglicherweise ein neues Target für die Therapie von neurologischen 
Erkrankungen sind, bei denen Glutamattoxizität und oxidativer Stress zur 
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DMSO Dimethylsulfoxide 
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ROS       Reactive oxygen species 
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